Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	SH3 domain binding	DOCK4 ABI1 WIPF1 INPP5D WIPF3 CBL SHANK2 INPP5J RAD9A	5.96e-07	143	136	9	GO:0017124
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	ABI1 MAP1A PPRC1 NACA SHC1 MAML1 MED14 ATG2A MED1 SRCAP WNK1 NUFIP1 NEFH YEATS2 KMT2C NCOR2 KMT2D SHANK2 ARID5B TNRC6A RERE BAIAP2 ZNF598 TOX2	9.79e-07	1160	136	24	GO:0030674
GeneOntologyMolecularFunction	molecular adaptor activity	ABI1 MAP1A PPRC1 NACA SHC1 MAML1 MED14 ATG2A MED1 SRCAP WNK1 DCTN1 NUFIP1 NEFH YEATS2 KMT2C NCOR2 KMT2D SHANK2 ARID5B TNRC6A RERE BAIAP2 ZNF598 TOX2	4.48e-06	1356	136	25	GO:0060090
GeneOntologyMolecularFunction	transcription coactivator activity	PPRC1 NACA MAML1 MED14 MED1 SRCAP KMT2C KMT2D ARID5B RERE TOX2	7.42e-06	303	136	11	GO:0003713
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	KMT2B KMT2C KMT2D	1.69e-05	8	136	3	GO:0140945
GeneOntologyMolecularFunction	histone H3K4 trimethyltransferase activity	KMT2B KMT2C KMT2D	3.58e-05	10	136	3	GO:0140999
GeneOntologyMolecularFunction	protein domain specific binding	DOCK4 ABI1 WIPF1 INPP5D WIPF3 DGKH MED1 CBL SHANK2 KCNH2 KCNJ4 CASKIN1 FHOD1 TNKS1BP1 BAIAP2 INPP5J RAD9A	9.57e-05	875	136	17	GO:0019904
GeneOntologyMolecularFunction	transcription coregulator activity	PPRC1 NACA MAML1 MED14 MED1 SRCAP YEATS2 KMT2C NCOR2 KMT2D ARID5B RERE TOX2	1.24e-04	562	136	13	GO:0003712
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	KMT2B KMT2C KMT2D	3.24e-04	20	136	3	GO:0042800
GeneOntologyMolecularFunction	inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity	INPP5D INPP5J	9.46e-04	7	136	2	GO:0052659
GeneOntologyMolecularFunction	phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity	INPP5D INPP5J	9.46e-04	7	136	2	GO:0034485
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	KMT2B KMT5C KMT2C KMT2D	1.20e-03	68	136	4	GO:0016279
GeneOntologyMolecularFunction	inositol-polyphosphate 5-phosphatase activity	INPP5D INPP5J	1.26e-03	8	136	2	GO:0004445
GeneOntologyMolecularFunction	inositol-1,4,5-trisphosphate 5-phosphatase activity	INPP5D INPP5J	1.26e-03	8	136	2	GO:0052658
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	KMT2B KMT5C KMT2C KMT2D	1.26e-03	69	136	4	GO:0016278
GeneOntologyMolecularFunction	histone methyltransferase activity	KMT2B KMT5C KMT2C KMT2D	1.41e-03	71	136	4	GO:0042054
GeneOntologyMolecularFunction	inositol tetrakisphosphate phosphatase activity	INPP5D INPP5J	1.61e-03	9	136	2	GO:0052743
GeneOntologyMolecularFunction	chromatin binding	SOX10 KMT5C MED1 CIC PHC2 NCOR2 ASXL3 FOXO4 RERE MBD5 TOX2 MNT CBX2	1.63e-03	739	136	13	GO:0003682
GeneOntologyMolecularFunction	phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity	INPP5D INPP5J	2.00e-03	10	136	2	GO:0004439
GeneOntologyMolecularFunction	eukaryotic initiation factor 4E binding	EIF4EBP1 EIF4EBP3	2.43e-03	11	136	2	GO:0008190
GeneOntologyMolecularFunction	phosphatidylinositol trisphosphate phosphatase activity	INPP5D INPP5J	2.43e-03	11	136	2	GO:0034594
GeneOntologyBiologicalProcess	regulation of supramolecular fiber organization	MAP1A MAP1B KATNB1 ARHGEF18 NAA80 TSC1 DCTN1 ARHGEF15 KANK1 XIRP2 FHOD1 BAIAP2 INPP5J	6.78e-06	438	136	13	GO:1902903
GeneOntologyBiologicalProcess	actin cytoskeleton organization	ABI1 WIPF1 WIPF3 SHC1 ARHGEF18 NAA80 TSC1 ARHGEF17 ARHGEF15 SLC4A2 KANK1 XIRP2 INF2 FHOD1 PHACTR4 FGD5 BAIAP2	2.21e-05	803	136	17	GO:0030036
GeneOntologyBiologicalProcess	regulation of cytoskeleton organization	MAP1A MAP1B KATNB1 ARHGEF18 NAA80 TSC1 DCTN1 ARHGEF15 SLC4A2 KANK1 XIRP2 FHOD1 BAIAP2 INPP5J	2.96e-05	579	136	14	GO:0051493
GeneOntologyBiologicalProcess	actin filament-based process	ABI1 WIPF1 WIPF3 SHC1 ARHGEF18 NAA80 TSC1 ARHGEF17 ARHGEF15 SLC4A2 KANK1 XIRP2 INF2 KCNH2 FHOD1 PHACTR4 FGD5 BAIAP2	3.15e-05	912	136	18	GO:0030029
GeneOntologyBiologicalProcess	small GTPase-mediated signal transduction	DOCK4 ARHGEF18 CBL ARHGEF17 ARHGEF15 KANK1 SRGAP1 RIN2 PHACTR4 NTN1 FGD5 ULK1 BAIAP2	5.82e-05	538	136	13	GO:0007264
GeneOntologyBiologicalProcess	supramolecular fiber organization	ABI1 WIPF1 MAP1A MAP1B KATNB1 WIPF3 ARHGEF18 NAA80 TSC1 DCTN1 ARHGEF15 NEFH KANK1 XIRP2 INF2 FHOD1 BAIAP2 INPP5J	5.88e-05	957	136	18	GO:0097435
GeneOntologyBiologicalProcess	actin filament organization	ABI1 WIPF1 WIPF3 ARHGEF18 NAA80 TSC1 ARHGEF15 KANK1 XIRP2 INF2 FHOD1 BAIAP2	1.42e-04	509	136	12	GO:0007015
GeneOntologyCellularComponent	nuclear protein-containing complex	KMT2B CTC1 ZCCHC8 BICRA MED14 MED1 SRCAP TEP1 POM121C PHC2 NUFIP1 KMT2C NCOR2 KMT2D POM121 ASXL3 SUGP1 RERE SAP130 AFF4 RAD9A CBX2	7.91e-05	1377	136	22	GO:0140513
HumanPheno	Hypertrichosis	SOX10 MAP1B OTUD5 BICRA KATNB1 HECTD4 SRCAP CASZ1 KMT2D ASXL3 RIN2 RERE MBD5 TRAPPC9 AFF4 RAI1	7.71e-07	425	48	16	HP:0000998
HumanPheno	Synophrys	SOX10 MAP1B BICRA KATNB1 HECTD4 ASXL3 MBD5 TRAPPC9 AFF4 RAI1	9.85e-06	195	48	10	HP:0000664
HumanPheno	Facial hypertrichosis	SOX10 MAP1B BICRA KATNB1 HECTD4 ASXL3 MBD5 TRAPPC9 AFF4 RAI1	1.60e-05	206	48	10	HP:0002219
HumanPheno	Abnormal hair pattern	SOX10 MAP1B OTUD5 BICRA KATNB1 HECTD4 TSC1 SRCAP CBL CASZ1 KMT2D ASXL3 RIN2 RERE MBD5 TRAPPC9 AFF4 RAI1	1.95e-05	676	48	18	HP:0010720
HumanPheno	Hirsutism	MAP1B OTUD5 SRCAP CASZ1 KMT2D ASXL3 RIN2 RERE MBD5 AFF4	2.42e-05	216	48	10	HP:0001007
HumanPheno	Medial flaring of the eyebrow	SOX10 MAP1B BICRA KATNB1 HECTD4 ASXL3 MBD5 TRAPPC9 AFF4 RAI1	3.87e-05	228	48	10	HP:0010747
HumanPheno	Functional abnormality of the gastrointestinal tract	SOX10 KMT2B WIPF1 MAP1B CTC1 BICRA COBLL1 KATNB1 HECTD4 TSC1 MUC5B SRCAP CBL WNK1 DCTN1 CASZ1 NEFH KMT2C KMT2D ASXL3 RERE PAX9 MBD5 AFF4 RAI1	4.50e-05	1270	48	25	HP:0012719
HumanPheno	Gastroesophageal reflux	KMT2B MAP1B BICRA HECTD4 MUC5B SRCAP WNK1 CASZ1 KMT2C KMT2D ASXL3 RERE MBD5 AFF4 RAI1	4.65e-05	517	48	15	HP:0002020
HumanPheno	Abnormal eyebrow morphology	SOX10 MAP1B CTC1 BICRA KATNB1 HECTD4 CBL CASZ1 KMT2C KMT2D ASXL3 RIN2 RERE MBD5 TRAPPC9 AFF4 RAI1	7.45e-05	674	48	17	HP:0000534
HumanPheno	Abnormal esophagus physiology	KMT2B MAP1B BICRA COBLL1 KATNB1 HECTD4 MUC5B SRCAP WNK1 DCTN1 CASZ1 NEFH KMT2C KMT2D ASXL3 RERE PAX9 MBD5 AFF4 RAI1	1.36e-04	933	48	20	HP:0025270
HumanPheno	Recurrent hand flapping	CIC ASXL3 MBD5 TRAPPC9	1.59e-04	30	48	4	HP:0100023
HumanPheno	Eclabion	MAP1B SRCAP KMT2C ASXL3 RIN2 PAX9 MBD5 RAI1	1.71e-04	172	48	8	HP:0012472
HumanPheno	Long eyelashes	BICRA HECTD4 SRCAP KMT2D ASXL3 MBD5 AFF4	1.76e-04	129	48	7	HP:0000527
HumanPheno	Abnormal hair quantity	SOX10 KMT2B MAP1B CTC1 OTUD5 BICRA KATNB1 HECTD4 SRCAP CBL CASZ1 KMT2D ASXL3 RIN2 RERE MBD5 TRAPPC9 AFF4 RAI1	2.27e-04	888	48	19	HP:0011362
HumanPheno	Abnormal thought pattern	MAP1B BICRA TSC1 SRCAP DCTN1 CIC CASZ1 ASXL3 RERE MBD5 TRAPPC9 RAI1	2.64e-04	404	48	12	HP:5200269
HumanPheno	Hypermetropia	KMT2B OTUD5 BICRA SRCAP CASZ1 KMT2C ASXL3 RERE MBD5 RAI1	2.74e-04	288	48	10	HP:0000540
MousePheno	lethality during fetal growth through weaning, incomplete penetrance	SOX10 KMT2B MAP1B ZCCHC8 MAML1 CC2D1A TSC1 CBL CIC SLC4A2 GGA3 FOXB1 SALL2 SHANK2 PHACTR4 ARID5B RERE BAIAP2 PAX9 MBD5 MNT AFF4 RAI1 CBX2	1.38e-05	1124	116	24	MP:0011112
MousePheno	ventricular hypoplasia	NACA SHC1 MED1 WNK1 CASZ1 XIRP2 SAP130	1.79e-05	99	116	7	MP:0000279
Domain	AT_hook	KMT2B SRCAP PRR12 KMT2C CBX2	1.08e-06	27	130	5	SM00384
Domain	AT_hook_DNA-bd_motif	KMT2B SRCAP PRR12 KMT2C CBX2	1.08e-06	27	130	5	IPR017956
Domain	FYrich_C	KMT2B KMT2C KMT2D	3.26e-06	5	130	3	IPR003889
Domain	FYrich_N	KMT2B KMT2C KMT2D	3.26e-06	5	130	3	IPR003888
Domain	FYRC	KMT2B KMT2C KMT2D	3.26e-06	5	130	3	SM00542
Domain	FYRN	KMT2B KMT2C KMT2D	3.26e-06	5	130	3	SM00541
Domain	FYRN	KMT2B KMT2C KMT2D	3.26e-06	5	130	3	PF05964
Domain	FYRC	KMT2B KMT2C KMT2D	3.26e-06	5	130	3	PF05965
Domain	FYRC	KMT2B KMT2C KMT2D	3.26e-06	5	130	3	PS51543
Domain	FYRN	KMT2B KMT2C KMT2D	3.26e-06	5	130	3	PS51542
Domain	WH2	WIPF1 COBLL1 WIPF3 INF2	3.82e-06	16	130	4	PF02205
Domain	WH2_dom	WIPF1 COBLL1 WIPF3 INF2	1.22e-05	21	130	4	IPR003124
Domain	EPHD	KMT2B KMT2C KMT2D RAI1	1.49e-05	22	130	4	PS51805
Domain	WH2	WIPF1 COBLL1 WIPF3 INF2	2.14e-05	24	130	4	PS51082
Domain	HMG_box	SOX10 CIC KMT2C KMT2D TOX2	3.32e-05	53	130	5	PF00505
Domain	HMG	SOX10 CIC KMT2C KMT2D TOX2	3.64e-05	54	130	5	SM00398
Domain	HMG_box_dom	SOX10 CIC KMT2C KMT2D TOX2	8.94e-05	65	130	5	IPR009071
Domain	WH2	WIPF1 WIPF3 INF2	1.13e-04	14	130	3	SM00246
Domain	SH3	DOCK4 ABI1 PPP1R13B SHANK2 SRGAP1 CASKIN1 BAIAP2 FYB2	1.36e-04	216	130	8	SM00326
Domain	eIF_4EBP	EIF4EBP1 EIF4EBP3	1.44e-04	3	130	2	PF05456
Domain	MAP1	MAP1A MAP1B	1.44e-04	3	130	2	IPR026074
Domain	EIF4EBP	EIF4EBP1 EIF4EBP3	1.44e-04	3	130	2	IPR008606
Domain	SH3_domain	DOCK4 ABI1 PPP1R13B SHANK2 SRGAP1 CASKIN1 BAIAP2 FYB2	1.55e-04	220	130	8	IPR001452
Domain	Post-SET_dom	KMT2B KMT2C KMT2D	1.73e-04	16	130	3	IPR003616
Domain	PostSET	KMT2B KMT2C KMT2D	1.73e-04	16	130	3	SM00508
Domain	POST_SET	KMT2B KMT2C KMT2D	1.73e-04	16	130	3	PS50868
Domain	SET	KMT2B KMT5C KMT2C KMT2D	1.86e-04	41	130	4	PF00856
Domain	SET	KMT2B KMT5C KMT2C KMT2D	2.92e-04	46	130	4	SM00317
Domain	SAM	PPFIA4 DGKH PHC2 SHANK2 CASKIN1	3.73e-04	88	130	5	SM00454
Domain	SET_dom	KMT2B KMT5C KMT2C KMT2D	4.03e-04	50	130	4	IPR001214
Domain	SET	KMT2B KMT5C KMT2C KMT2D	4.03e-04	50	130	4	PS50280
Domain	SAM_DOMAIN	PPFIA4 DGKH PHC2 SHANK2 CASKIN1	5.31e-04	95	130	5	PS50105
Domain	ZF_PHD_2	KMT2B KMT2C KMT2D ASXL3 RAI1	5.31e-04	95	130	5	PS50016
Domain	ZF_PHD_1	KMT2B KMT2C KMT2D ASXL3 RAI1	5.57e-04	96	130	5	PS01359
Domain	-	SOX10 CIC KMT2D TOX2	5.81e-04	55	130	4	1.10.30.10
Domain	SAM	PPFIA4 DGKH PHC2 SHANK2 CASKIN1	5.84e-04	97	130	5	IPR001660
Domain	SH3	DOCK4 ABI1 PPP1R13B SHANK2 SRGAP1 CASKIN1 BAIAP2	7.98e-04	216	130	7	PS50002
Domain	-	PPFIA4 DGKH PHC2 SHANK2 CASKIN1	8.74e-04	106	130	5	1.10.150.50
Domain	HMGI/Y_DNA-bd_CS	PRR12 KMT2C CBX2	1.28e-03	31	130	3	IPR000637
Domain	RhoGEF	ARHGEF18 ARHGEF17 ARHGEF15 FGD5	1.29e-03	68	130	4	SM00325
Domain	SAM_1	PPFIA4 PHC2 SHANK2 CASKIN1	1.29e-03	68	130	4	PF00536
Domain	SAM/pointed	PPFIA4 DGKH PHC2 SHANK2 CASKIN1	1.36e-03	117	130	5	IPR013761
Domain	RhoGEF	ARHGEF18 ARHGEF17 ARHGEF15 FGD5	1.44e-03	70	130	4	PF00621
Domain	DH_2	ARHGEF18 ARHGEF17 ARHGEF15 FGD5	1.44e-03	70	130	4	PS50010
Domain	-	ARHGEF18 ARHGEF17 ARHGEF15 FGD5	1.52e-03	71	130	4	1.20.900.10
Domain	DH-domain	ARHGEF18 ARHGEF17 ARHGEF15 FGD5	1.52e-03	71	130	4	IPR000219
Domain	IPPc	INPP5D INPP5J	2.09e-03	10	130	2	IPR000300
Domain	IPPc	INPP5D INPP5J	2.09e-03	10	130	2	SM00128
Domain	GBD/FH3_dom	INF2 FHOD1	2.54e-03	11	130	2	IPR014768
Domain	GBD_FH3	INF2 FHOD1	2.54e-03	11	130	2	PS51232
Domain	SH3_2	DOCK4 SHANK2 CASKIN1 BAIAP2	3.06e-03	86	130	4	PF07653
Domain	SH3_2	DOCK4 SHANK2 CASKIN1 BAIAP2	3.06e-03	86	130	4	IPR011511
Domain	PHD	KMT2B KMT2C KMT2D RAI1	3.47e-03	89	130	4	SM00249
Domain	Znf_PHD	KMT2B KMT2C KMT2D RAI1	3.75e-03	91	130	4	IPR001965
Domain	TF_fork_head_CS_2	FOXB2 FOXB1 FOXO4	4.02e-03	46	130	3	IPR030456
Domain	K_chnl_volt-dep_EAG/ELK/ERG	HCN3 KCNH2	4.14e-03	14	130	2	IPR003938
Domain	TF_fork_head_CS_1	FOXB2 FOXB1 FOXO4	4.27e-03	47	130	3	IPR018122
Domain	FH2	INF2 FHOD1	4.76e-03	15	130	2	PS51444
Domain	FH2_Formin	INF2 FHOD1	4.76e-03	15	130	2	IPR015425
Domain	FH2	INF2 FHOD1	4.76e-03	15	130	2	PF02181
Domain	FH2	INF2 FHOD1	4.76e-03	15	130	2	SM00498
Domain	FH	FOXB2 FOXB1 FOXO4	4.81e-03	49	130	3	SM00339
Domain	FORK_HEAD_1	FOXB2 FOXB1 FOXO4	4.81e-03	49	130	3	PS00657
Domain	FORK_HEAD_2	FOXB2 FOXB1 FOXO4	4.81e-03	49	130	3	PS00658
Domain	Fork_head_dom	FOXB2 FOXB1 FOXO4	4.81e-03	49	130	3	IPR001766
Domain	FORK_HEAD_3	FOXB2 FOXB1 FOXO4	4.81e-03	49	130	3	PS50039
Domain	Forkhead	FOXB2 FOXB1 FOXO4	4.81e-03	49	130	3	PF00250
Domain	Laminin_N	NTN3 NTN1	5.41e-03	16	130	2	IPR008211
Domain	AT_hook	PRR12 KMT2C	5.41e-03	16	130	2	PF02178
Domain	LamNT	NTN3 NTN1	5.41e-03	16	130	2	SM00136
Domain	LAMININ_NTER	NTN3 NTN1	5.41e-03	16	130	2	PS51117
Domain	Laminin_N	NTN3 NTN1	5.41e-03	16	130	2	PF00055
Domain	C345C	NTN3 NTN1	6.11e-03	17	130	2	SM00643
Domain	HMG_BOX_2	SOX10 CIC TOX2	6.31e-03	54	130	3	PS50118
Pathway	REACTOME_RAC1_GTPASE_CYCLE	DOCK4 ABI1 WIPF1 WIPF3 ARHGEF18 ARHGEF15 SRGAP1 FGD5 BAIAP2	1.00e-05	184	106	9	M41809
Pathway	KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119	PHC2 ASXL3 MBD5 CBX2	3.97e-05	26	106	4	M47923
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	NDOR1 KMT2B ZNF628 CTC1 PPRC1 BICRA KMT5C HECTD4 FBRS SHC1 MAML1 MED14 C15orf39 CC2D1A ATG2A SRCAP TEP1 POM121C WNK1 DCTN1 CIC CASZ1 PHC2 GGA3 ZNF503 PRR12 KMT2C NCOR2 KMT2D SHANK2 INF2 KCNH2 CASKIN1 TNKS1BP1 ULK1 MBD5 TRAPPC9 RAI1 RAD9A CBX2	6.94e-27	1105	141	40	35748872
Pubmed	Human transcription factor protein interaction networks.	SOX10 KMT2B BICRA SEC24A NACA FBRS MAML1 PPP1R13B C15orf39 CC2D1A SRCAP POM121C CIC ZNF503 PRR12 YEATS2 KMT2C NCOR2 KMT2D SALL2 ARID5B TNRC6A MKI67 SUGP1 RBM6 RERE PAX9 SAP130 PRRC2A MNT TRAPPC9 CBX2	2.04e-15	1429	141	32	35140242
Pubmed	Interaction network of human early embryonic transcription factors.	KMT2B BICRA FBRS MAML1 C15orf39 TPRX2 POM121C ZNF503 PRR12 KMT2C NCOR2 KMT2D ASXL3 ARID5B MKI67 RERE RAI1	9.06e-14	351	141	17	38297188
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	ZCCHC8 FBRS MAML1 MED14 MED1 CIC CASZ1 PRR12 KMT2D ARID5B SUGP1 RERE SAP130 AFF4 RAI1	3.49e-13	268	141	15	33640491
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	EHBP1 KMT2B ZCCHC8 FBRS C15orf39 DCTN1 CIC PRR12 YEATS2 NCOR2 KMT2D SALL2 ARID5B TNRC6A TNKS1BP1 RERE GOLGA3	1.50e-12	418	141	17	34709266
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	DOCK4 MAP1A OTUD5 ZCCHC8 FBRS MAML1 PPP1R13B C15orf39 TSC1 SRCAP WNK1 CIC YEATS2 NCOR2 SALL2 ARID5B TNRC6A RBM6 TNKS1BP1	3.77e-12	588	141	19	38580884
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	KMT2B MAP1B MED14 PPP1R13B CC2D1A MED1 SRCAP CBL DCTN1 GGA3 YEATS2 KMT2C KMT2D PHACTR4 TNKS1BP1 ZNF598 SAP130 PRRC2A	1.14e-11	549	141	18	38280479
Pubmed	A human MAP kinase interactome.	EHBP1 WIPF1 MAP1A BICRA COBLL1 PPP1R13B CBL POM121C WNK1 DCTN1 CIC KMT2C POM121 FHOD1 TNRC6A BAIAP2 MBD5	1.62e-11	486	141	17	20936779
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SPATA31E1 MAP1A BICRA INPP5D ARHGEF18 ATG2A POM121C WNK1 CIC GGA3 NCOR2 POM121 XIRP2 EIF4EBP1 IGSF9B SAP130	2.66e-11	430	141	16	35044719
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	EHBP1 MAP1A MAP1B ZCCHC8 NACA CC2D1A TSC1 MED1 SRCAP POM121C WNK1 DCTN1 CIC GGA3 YEATS2 FHOD1 MKI67 SUGP1 TNKS1BP1 ZNF598 PRRC2A AFF4	3.18e-11	934	141	22	33916271
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DOCK4 EHBP1 ABI1 MAP1B ZCCHC8 SEC24A COBLL1 MAP3K14 CC2D1A CBL ARHGEF17 WNK1 CIC SRGAP1 PHACTR4 FOXO4 TNKS1BP1 BAIAP2 ZNF598 TRAPPC9 CNOT4	4.94e-11	861	141	21	36931259
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	SEC24A FBRS MAML1 POM121C CIC ZNF503 PRR12 YEATS2 KMT2C NCOR2 KMT2D POM121 TNRC6A RBM6 SAP130 RAI1	6.54e-11	457	141	16	32344865
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	KMT2B WIPF1 BICRA INPP5D MAML1 MED14 C15orf39 CC2D1A MED1 CIC ZNF503 PRR12 YEATS2 KMT2C NCOR2 KMT2D MKI67 SUGP1 C2orf49 SAP130 PRRC2A MNT RAI1	1.20e-10	1103	141	23	34189442
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	EHBP1 MAP1B BICRA HECTD4 ARHGEF18 DGKH TEP1 CASZ1 YEATS2 KMT2C NCOR2 SHANK2 INF2 RIN2 ARID5B RBM6 ZFHX2 NTN1 IGSF9B RERE BAIAP2 MBD5 SAP130 TRAPPC9 AFF4 RAI1	2.98e-10	1489	141	26	28611215
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	BICRA FBRS MAML1 C15orf39 CIC ZNF503 PRR12 NCOR2 TNRC6A CNOT4	7.14e-10	152	141	10	38360978
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	ABI1 KMT2B ZCCHC8 COBLL1 WIPF3 MED1 SRCAP DCTN1 CIC YEATS2 INF2 PHACTR4 MKI67 SUGP1 BAIAP2	2.58e-09	506	141	15	30890647
Pubmed	Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription.	KMT2B MED14 MED1 KMT2C TNRC6A TNKS1BP1 AFF4	4.43e-09	59	141	7	28813667
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	FBRS MAML1 MUC16 MED1 CBL POM121C CIC CASZ1 YEATS2 NCOR2 KMT2D ASXL3 ARID5B SUGP1 FGD5 RAI1	7.91e-09	638	141	16	31182584
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	KMT2B OTUD5 ZCCHC8 MED14 MED1 CIC PHC2 YEATS2 NCOR2 KMT2D FHOD1 PHACTR4 MKI67 RBM6 TNKS1BP1 RERE PRRC2A	1.84e-08	774	141	17	15302935
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	EHBP1 OTUD5 ZCCHC8 SEC24A NACA KATNB1 CC2D1A POM121C PHC2 SALL2 POM121 PMPCA EIF4EBP1 SUGP1 RBM6 BAIAP2 ZNF598 C2orf49 GOLGA3	2.84e-08	1007	141	19	34597346
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	DOCK4 SEC24A KATNB1 MAML1 PPP1R13B CC2D1A TSC1 ATG2A FCHO2 DCTN1 GGA3 PHACTR4 TNRC6A POC5 BAIAP2 ZNF598 CNOT4	7.45e-08	853	141	17	28718761
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	BICRA FBRS MAML1 C15orf39 CASZ1 ZNF503 PRR12 YEATS2 KMT2C NCOR2 KMT2D ARID5B	9.05e-08	398	141	12	35016035
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	DOCK4 MAP1B HCN3 WIPF3 SHC1 CBL CIC NUFIP1 KMT2C KANK1 INF2 FGD5 POC5 MBD5 CBX2	1.49e-07	689	141	15	36543142
Pubmed	Myelinating Schwann cells and Netrin-1 control intra-nervous vascularization of the developing mouse sciatic nerve.	SOX10 NEFH MKI67 NTN1	1.80e-07	13	141	4	35019839
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	EHBP1 ZCCHC8 SEC24A FBRS SHC1 MAML1 C15orf39 CC2D1A ATG2A FCHO2 CBL WNK1 NUFIP1 SHANK2 SUGP1 TNKS1BP1 POC5 CNOT4	2.36e-07	1038	141	18	26673895
Pubmed	Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation.	KMT2B KMT2C KMT2D	2.60e-07	4	141	3	19221051
Pubmed	Activation of eIF4E-binding-protein-1 rescues mTORC1-induced sarcopenia by expanding lysosomal degradation capacity.	TSC1 EIF4EBP1 ULK1	2.60e-07	4	141	3	36398408
Pubmed	Mutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in mice.	NDOR1 KMT2B KMT2D	2.60e-07	4	141	3	23826075
Pubmed	A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity.	KMT2B KMT2C KMT2D	2.60e-07	4	141	3	23129768
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	WIPF1 KATNB1 CBL POM121 SRGAP1 PHACTR4 PRRC2A	3.07e-07	108	141	7	19531213
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ABI1 HCN3 HECTD4 ARHGEF18 TSC1 DCTN1 NEFH NCOR2 SHANK2 KCNJ4 CASKIN1 NCAN BAIAP2 PRRC2A GOLGA3 AFF4 RAI1	4.09e-07	963	141	17	28671696
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	CTC1 MUC16 POM121C CIC PRR12 KMT2D SHANK2 ASXL3 TNRC6A ZFHX2 FGD5 IGSF9B GOLGA3	4.38e-07	552	141	13	10737800
Pubmed	The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors.	INPP5D SHC1 CBL	6.48e-07	5	141	3	9393882
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	EHBP1 PPFIA4 COBLL1 ARHGEF18 POM121C WNK1 CASZ1 ARHGEF15 PRR12 POM121 MBD5 TRAPPC9	8.80e-07	493	141	12	15368895
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	MAP1A ARHGEF18 PRR12 YEATS2 NCOR2 KMT2D TNRC6A MKI67	9.16e-07	184	141	8	32908313
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	MED1 CIC PRR12 NCOR2 KMT2D SAP130	1.17e-06	83	141	6	28794006
Pubmed	Automated yeast two-hybrid screening for nuclear receptor-interacting proteins.	MED14 MED1 DCTN1 ARHGEF15 NCOR2 FHOD1 REPS2	1.26e-06	133	141	7	15604093
Pubmed	Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases.	KMT2B KMT2C KMT2D	1.29e-06	6	141	3	17021013
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	ZCCHC8 MED14 MED1 SRCAP POM121C KMT2D MKI67 TNKS1BP1 SAP130 AFF4	1.43e-06	341	141	10	32971831
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ABI1 MAP1A MAP1B HCN3 NEFH SHANK2 CASKIN1 TNKS1BP1 BAIAP2 PRRC2A	1.67e-06	347	141	10	17114649
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	MAP1B BICRA NUTM2A MED1 CIC YEATS2 NCOR2 MKI67 SUGP1 RBM6 C2orf49 SAP130 PRRC2A AFF4 RAI1 CBX2	1.78e-06	954	141	16	36373674
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	NACA MAML1 ARHGEF18 TSC1 WNK1 SLC4A2 ZNF503 YEATS2 KANK1 TNRC6A SUGP1 POC5 BAIAP2 PRR11	1.86e-06	733	141	14	34672954
Pubmed	Structural insights into trans-histone regulation of H3K4 methylation by unique histone H4 binding of MLL3/4.	KMT2B KMT2C KMT2D	2.26e-06	7	141	3	30604749
Pubmed	ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity.	KMT2B KMT2C KMT2D	2.26e-06	7	141	3	19556342
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ABI1 KMT2B ZCCHC8 NACA MAML1 MED14 MED1 CIC CASZ1 PHC2 PRR12 KMT2C SHANK2 TNRC6A RBM6 BAIAP2 PRR11 ZNF598 PRRC2A AFF4	2.82e-06	1497	141	20	31527615
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	EHBP1 ABI1 COBLL1 PPP1R13B CC2D1A CBL GGA3 SHANK2 PHACTR4 TNKS1BP1 BAIAP2 GOLGA3	3.59e-06	565	141	12	25468996
Pubmed	The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases.	KMT2B KMT2C KMT2D	3.60e-06	8	141	3	22266653
Pubmed	Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.	KMT2B KMT2C KMT2D	3.60e-06	8	141	3	23130995
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	KMT2B SRCAP ARHGEF17 WNK1 CIC SALL2	4.37e-06	104	141	6	9205841
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	KMT2B ZCCHC8 MED1 SRCAP POM121C CIC CASZ1 PHC2 PRR12 YEATS2 KMT2C NCOR2 KMT2D ARID5B MKI67 SAP130 MNT RAI1	5.35e-06	1294	141	18	30804502
Pubmed	Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.	KMT2B KMT2C KMT2D	5.38e-06	9	141	3	22665483
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	ZCCHC8 MED14 MED1 YEATS2 KMT2C KMT2D SALL2	5.71e-06	167	141	7	20362541
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	MAP1B BICRA MED1 WNK1 ZNF503 NCOR2 MKI67 TNKS1BP1 SAP130 PRRC2A	5.74e-06	399	141	10	35987950
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	SEC24A DUSP4 SHC1 PPP1R13B TSC1 FCHO2 CIC NCOR2 KMT2D PMPCA TNRC6A MKI67 POC5 BAIAP2 PRRC2A CBX2	5.95e-06	1049	141	16	27880917
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	KMT2B FBRS PHC2 ZNF503 YEATS2 KMT2C KMT2D RERE MBD5 MNT CBX2	6.07e-06	495	141	11	27705803
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DOCK4 PPRC1 TSC1 ARHGEF17 GGA3 NEFH YEATS2 KANK1 ULK1 RERE	6.83e-06	407	141	10	12693553
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	ZCCHC8 COBLL1 CC2D1A FCHO2 MED1 CBL WNK1 MKI67 RBM6 TNKS1BP1 PRRC2A	7.05e-06	503	141	11	16964243
Pubmed	Protein phosphatase 1α interacting proteins in the human brain.	PPP1R13B DCTN1 PRR16 KANK1 ULK1	8.05e-06	67	141	5	22321011
Pubmed	USP7 Regulates Cytokinesis through FBXO38 and KIF20B.	OTUD5 MAML1 POM121C YEATS2 NCOR2 ARID5B	8.21e-06	116	141	6	30804394
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	ABI1 DCTN1 NEFH SHANK2 KCNJ4 CASKIN1 NCAN BAIAP2	9.12e-06	251	141	8	27507650
Pubmed	Genetic interaction mapping in mammalian cells using CRISPR interference.	MED14 SRCAP PHC2 KMT2D CBX2	9.30e-06	69	141	5	28481362
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	C15orf39 POM121C PRR12 NCOR2 TNRC6A RBM6 RAI1	9.33e-06	180	141	7	35198878
Pubmed	Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.	KMT2B MED14 ARHGEF17 YEATS2 KMT2C KMT2D	9.51e-06	119	141	6	23508102
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	ABI1 MAP1B MAML1 DCTN1 CIC CASZ1 NCOR2 FOXB1 KMT2D SALL2 FOXO4 ZNF598 SAP130 MNT	1.10e-05	857	141	14	25609649
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	EHBP1 SEC24A PPP1R13B POM121C GGA3 POM121 TNRC6A MKI67	1.28e-05	263	141	8	34702444
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MAP1A ZCCHC8 BICRA FBRS SRCAP TEP1 POM121C NUFIP1 YEATS2 NCOR2 SALL2 TNRC6A RERE SAP130 AFF4 RAI1	1.28e-05	1116	141	16	31753913
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	PPRC1 NACA MED14 CC2D1A DCTN1 ARHGEF15 NCOR2 POM121 MKI67 RBM6 FGD5 GOLGA3 INPP5J	1.31e-05	754	141	13	35906200
Pubmed	Spatial proteomics reveal that the protein phosphatase PTP1B interacts with and may modify tyrosine phosphorylation of the rhomboid protease RHBDL4.	EHBP1 SEC24A POM121C INF2 MKI67 PRR11 PRRC2A	1.37e-05	191	141	7	31177093
Pubmed	Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.	KMT2B KMT2C KMT2D	1.40e-05	12	141	3	27563068
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	MAP1A MAP1B NAA80 MED1 YEATS2 NCOR2 SALL2 FHOD1 SUGP1 TNKS1BP1	1.45e-05	444	141	10	34795231
Pubmed	NUTM2A-CIC fusion small round cell sarcoma: a genetically distinct variant of CIC-rearranged sarcoma.	NUTM2A CIC	1.63e-05	2	141	2	28188754
Pubmed	Regulation of microtubule-associated protein 1B (MAP1B) subunit composition.	MAP1A MAP1B	1.63e-05	2	141	2	11002287
Pubmed	Prognostic significance of expression of eukaryotic initiation factor 4E and 4E binding protein 1 in patients with pathological stage I invasive lung adenocarcinoma.	EIF4EBP1 EIF4EBP3	1.63e-05	2	141	2	20621385
Pubmed	Kabuki syndrome stem cell models reveal locus specificity of histone methyltransferase 2D (KMT2D/MLL4).	KMT2B KMT2D	1.63e-05	2	141	2	35640156
Pubmed	KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies.	KMT2C KMT2D	1.63e-05	2	141	2	31924266
Pubmed	Divergent properties of mouse netrins.	NTN3 NTN1	1.63e-05	2	141	2	10381568
Pubmed	Cloning and characterization of human SHIP, the 145-kD inositol 5-phosphatase that associates with SHC after cytokine stimulation.	INPP5D SHC1	1.63e-05	2	141	2	8874179
Pubmed	Abi-1 forms an epidermal growth factor-inducible complex with Cbl: role in receptor endocytosis.	ABI1 CBL	1.63e-05	2	141	2	17395426
Pubmed	Multiple formin proteins participate in glioblastoma migration.	INF2 FHOD1	1.63e-05	2	141	2	32727404
Pubmed	Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability.	KMT2C KMT2D	1.63e-05	2	141	2	28967912
Pubmed	Heterotypic complex formation between subunits of microtubule-associated proteins 1A and 1B is due to interaction of conserved domains.	MAP1A MAP1B	1.63e-05	2	141	2	16996626
Pubmed	Netrin signaling mediates survival of dormant epithelial ovarian cancer cells.	NTN3 NTN1	1.63e-05	2	141	2	39023520
Pubmed	The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase.	INPP5D SHC1	1.63e-05	2	141	2	8643691
Pubmed	TRAPPC9 mediates the interaction between p150 and COPII vesicles at the target membrane.	DCTN1 TRAPPC9	1.63e-05	2	141	2	22279557
Pubmed	The mouse and rat MAP1B genes: genomic organization and alternative transcription.	MAP1A MAP1B	1.63e-05	2	141	2	9615228
Pubmed	Phenotypic and molecular convergence of 2q23.1 deletion syndrome with other neurodevelopmental syndromes associated with autism spectrum disorder.	MBD5 RAI1	1.63e-05	2	141	2	25853262
Pubmed	Delayed development of nervous system in mice homozygous for disrupted microtubule-associated protein 1B (MAP1B) gene.	MAP1A MAP1B	1.63e-05	2	141	2	9199175
Pubmed	Association of KMT2C/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer.	KMT2C KMT2D	1.63e-05	2	141	2	36601880
Pubmed	Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.	KMT2C KMT2D	1.63e-05	2	141	2	28483418
Pubmed	Deletion of long-range sequences at Sox10 compromises developmental expression in a mouse model of Waardenburg-Shah (WS4) syndrome.	SOX10 NEFH	1.63e-05	2	141	2	16330480
Pubmed	Cloning of human microtubule-associated protein 1B and the identification of a related gene on chromosome 15.	MAP1A MAP1B	1.63e-05	2	141	2	7806212
Pubmed	Stage-dependent regulation of oligodendrocyte development and enhancement of myelin repair by dominant negative Master-mind 1 protein.	SOX10 MAML1	1.63e-05	2	141	2	31038233
Pubmed	The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape.	KMT2C KMT2D	1.63e-05	2	141	2	34156443
Pubmed	Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma.	KMT2C KMT2D	1.63e-05	2	141	2	27280393
Pubmed	Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiation.	KMT2C KMT2D	1.63e-05	2	141	2	36869380
Pubmed	Comparison of methylation episignatures in KMT2B- and KMT2D-related human disorders.	KMT2B KMT2D	1.63e-05	2	141	2	35506254
Pubmed	A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma: a genetically distinct variant of Ewing-like sarcoma.	CIC FOXO4	1.63e-05	2	141	2	25007147
Pubmed	Neuronal abnormalities in microtubule-associated protein 1B mutant mice.	MAP1A MAP1B	1.63e-05	2	141	2	8577753
Pubmed	Molecular cloning of microtubule-associated protein 1 (MAP1A) and microtubule-associated protein 5 (MAP1B): identification of distinct genes and their differential expression in developing brain.	MAP1A MAP1B	1.63e-05	2	141	2	2355215
Pubmed	The formins FHOD1 and INF2 regulate inter- and intra-structural contractility of podosomes.	INF2 FHOD1	1.63e-05	2	141	2	26621033
Interaction	TOP3B interactions	NDOR1 KMT2B ZNF628 CTC1 PPRC1 BICRA SEC24A KMT5C HECTD4 FBRS SHC1 MAML1 MED14 C15orf39 CC2D1A ATG2A SRCAP TEP1 POM121C WNK1 DCTN1 CIC CASZ1 PHC2 GGA3 ZNF503 PRR12 KMT2C NCOR2 KMT2D SHANK2 INF2 KCNH2 CASKIN1 TNKS1BP1 ULK1 MBD5 ZNF598 PRRC2A TRAPPC9 RAI1 RAD9A CBX2	6.40e-17	1470	137	43	int:TOP3B
Interaction	TLE3 interactions	SEC24A FBRS MAML1 C15orf39 TPRX2 CBL CIC ZNF503 PRR12 NCOR2 FOXB1 KMT2D POM121 ARID5B TNRC6A TNKS1BP1 RERE PAX9 SAP130 CNOT4	1.12e-12	376	137	20	int:TLE3
Interaction	SP7 interactions	KMT2B BICRA FBRS MAML1 C15orf39 CBL CIC ZNF503 PRR12 KMT2C NCOR2 KMT2D ARID5B SUGP1 RERE SAP130	2.78e-10	304	137	16	int:SP7
Interaction	GSC interactions	FBRS C15orf39 ZNF503 PRR12 KMT2C NCOR2 KMT2D ASXL3 ARID5B RERE	3.88e-10	87	137	10	int:GSC
Interaction	PAX9 interactions	FBRS MAML1 C15orf39 CIC ZNF503 PRR12 KMT2C NCOR2 KMT2D PAX9 SAP130	1.39e-09	130	137	11	int:PAX9
Interaction	SOX7 interactions	FBRS MAML1 C15orf39 CASZ1 PRR12 KMT2C NCOR2 KMT2D ARID5B	4.58e-09	82	137	9	int:SOX7
Interaction	FEV interactions	KMT2B BICRA FBRS MAML1 C15orf39 CIC ZNF503 PRR12 KMT2C NCOR2 KMT2D CBX2	1.46e-08	203	137	12	int:FEV
Interaction	ASF1A interactions	KMT2B BICRA SRCAP CASZ1 YEATS2 NCOR2 KMT2D SALL2 ARID5B SUGP1 SAP130 RAI1 CBX2	1.57e-08	249	137	13	int:ASF1A
Interaction	NUP35 interactions	SEC24A FBRS MAML1 POM121C CIC ZNF503 PRR12 YEATS2 KMT2C NCOR2 KMT2D POM121 TNRC6A RBM6 SAP130 RAI1	3.22e-08	424	137	16	int:NUP35
Interaction	NCOA6 interactions	KMT2B TPRX2 MED1 KMT2C NCOR2 KMT2D FHOD1 TNRC6A MKI67 PAX9	5.73e-08	145	137	10	int:NCOA6
Interaction	PFN1 interactions	DOCK4 ABI1 MAP1A COBLL1 WIPF3 NAA80 TSC1 FCHO2 CBL WNK1 GGA3 INF2 FHOD1 TNKS1BP1 BAIAP2 GOLGA3 AFF4	6.85e-08	509	137	17	int:PFN1
Interaction	KDM1A interactions	EHBP1 KMT2B ZCCHC8 FBRS SHC1 C15orf39 TPRX2 TSC1 DCTN1 CIC PHC2 PRR12 YEATS2 NCOR2 KMT2D SALL2 ARID5B TNRC6A TNKS1BP1 RERE BAIAP2 ZNF598 GOLGA3	9.03e-08	941	137	23	int:KDM1A
Interaction	VASP interactions	ABI1 MAP1A SEC24A COBLL1 PPP1R13B CBL XIRP2 INF2 FHOD1 PHACTR4 TNRC6A TNKS1BP1 BAIAP2	1.11e-07	294	137	13	int:VASP
Interaction	GATA2 interactions	FBRS MED1 CIC ZNF503 PRR12 KMT2C NCOR2 KMT2D ARID5B SAP130 TRAPPC9	1.18e-07	199	137	11	int:GATA2
Interaction	PAX7 interactions	FBRS MAML1 CIC ZNF503 PRR12 KMT2C NCOR2 KMT2D SAP130	1.74e-07	124	137	9	int:PAX7
Interaction	NAA40 interactions	EHBP1 MAP1A MAP1B ZCCHC8 NACA CC2D1A TSC1 MED1 SRCAP POM121C WNK1 DCTN1 CIC GGA3 YEATS2 FOXB1 FHOD1 MKI67 SUGP1 TNKS1BP1 ZNF598 PRRC2A AFF4	1.80e-07	978	137	23	int:NAA40
Interaction	ACTC1 interactions	ABI1 KMT2B WIPF1 ZCCHC8 BICRA COBLL1 WIPF3 NAA80 MED1 SRCAP DCTN1 CIC YEATS2 INF2 PHACTR4 MKI67 SUGP1 FGD5 BAIAP2	2.45e-07	694	137	19	int:ACTC1
Interaction	RCOR1 interactions	EHBP1 KMT2B ZCCHC8 FBRS C15orf39 TPRX2 DCTN1 CIC YEATS2 NCOR2 KMT2D SALL2 ARID5B MKI67 TNKS1BP1 GOLGA3	2.59e-07	494	137	16	int:RCOR1
Interaction	EGR2 interactions	SOX10 BICRA FBRS MAML1 C15orf39 PRR12 KMT2C NCOR2 KMT2D RERE	2.70e-07	171	137	10	int:EGR2
Interaction	ERG interactions	SOX10 BICRA FBRS MAML1 C15orf39 CIC PRR12 KMT2C NCOR2 KMT2D RERE	3.72e-07	223	137	11	int:ERG
Interaction	YWHAH interactions	DOCK4 EHBP1 ABI1 ZCCHC8 SEC24A COBLL1 HECTD4 CC2D1A TSC1 MED1 CBL ARHGEF17 WNK1 DCTN1 CIC KANK1 KCNH2 SRGAP1 PHACTR4 FOXO4 TNKS1BP1 BAIAP2 TRAPPC9 CNOT4	3.81e-07	1102	137	24	int:YWHAH
Interaction	HNF4A interactions	KMT2B BICRA MED14 MED1 SRCAP CIC PRR12 YEATS2 KMT2C NCOR2 KMT2D SAP130	4.01e-07	275	137	12	int:HNF4A
Interaction	NFIX interactions	SOX10 KMT2B BICRA SRCAP CIC PRR12 KMT2C NCOR2 KMT2D PAX9 SAP130	4.44e-07	227	137	11	int:NFIX
Interaction	NFIB interactions	SOX10 FBRS MAML1 CIC PRR12 KMT2C NCOR2 KMT2D PAX9	5.54e-07	142	137	9	int:NFIB
Interaction	ATN1 interactions	KMT2B TSC1 TEP1 ZNF503 YEATS2 KMT2C RERE BAIAP2 PAX9 PRRC2A	6.16e-07	187	137	10	int:ATN1
Interaction	PHF21A interactions	EHBP1 KMT2B ZCCHC8 FBRS C15orf39 CIC YEATS2 KMT2D SALL2 ARID5B TNRC6A TNKS1BP1 GOLGA3	6.43e-07	343	137	13	int:PHF21A
Interaction	HNF1B interactions	SOX10 BICRA MAML1 CIC PRR12 KMT2C NCOR2 KMT2D ARID5B SAP130	7.12e-07	190	137	10	int:HNF1B
Interaction	AR interactions	ZCCHC8 HECTD4 FBRS SHC1 MAML1 MED14 MED1 SRCAP CIC CASZ1 PRR12 KMT2C NCOR2 KMT2D ARID5B SUGP1 RERE REPS2 SAP130 AFF4 RAI1 RAD9A	9.24e-07	992	137	22	int:AR
Interaction	TBR1 interactions	FBRS MAML1 CIC ZNF503 PRR12 KMT2C NCOR2 KMT2D	1.04e-06	113	137	8	int:TBR1
Interaction	TBXT interactions	FBRS MAML1 CIC PRR12 KMT2C NCOR2 KMT2D SAP130	1.27e-06	116	137	8	int:TBXT
Interaction	CRX interactions	SOX10 BICRA FBRS MAML1 C15orf39 PRR12 KMT2C NCOR2 KMT2D RERE RAI1	1.34e-06	254	137	11	int:CRX
Interaction	KDM6A interactions	SOX10 KMT2B TPRX2 YEATS2 KMT2C KMT2D ASXL3 RERE PAX9	1.67e-06	162	137	9	int:KDM6A
Interaction	NFIC interactions	SOX10 SEC24A FBRS CIC PRR12 NCOR2 KMT2D MKI67 PAX9 SAP130	1.77e-06	210	137	10	int:NFIC
Interaction	IRF4 interactions	FBRS CBL CIC PRR12 KMT2C NCOR2 KMT2D	1.83e-06	85	137	7	int:IRF4
Interaction	ASH2L interactions	KMT2B ZCCHC8 MED14 TPRX2 SRCAP YEATS2 KMT2C KMT2D TNRC6A MKI67 RERE	2.03e-06	265	137	11	int:ASH2L
Interaction	KLF8 interactions	KMT2B BICRA FBRS POM121C CIC PRR12 YEATS2 NCOR2 KMT2D SAP130 PRRC2A MNT	2.63e-06	329	137	12	int:KLF8
Interaction	ACTG1 interactions	ABI1 WIPF1 MAP1A COBLL1 WIPF3 SHC1 SRCAP DCTN1 INF2 ASXL3 FHOD1 PHACTR4 BAIAP2 PRR11 ZNF598	2.64e-06	520	137	15	int:ACTG1
Interaction	TLX1 interactions	FBRS MAML1 CIC ZNF503 PRR12 KMT2C NCOR2 KMT2D SAP130	3.16e-06	175	137	9	int:TLX1
Interaction	CEBPA interactions	SOX10 KMT2B WIPF1 BICRA INPP5D MAML1 MED14 C15orf39 CC2D1A MED1 CIC ZNF503 PRR12 YEATS2 KMT2C NCOR2 KMT2D MKI67 SUGP1 C2orf49 SAP130 PRRC2A MNT RAI1	3.28e-06	1245	137	24	int:CEBPA
Interaction	YWHAE interactions	ABI1 MAP1B SEC24A COBLL1 SHC1 TSC1 CBL WNK1 DCTN1 CIC NCOR2 KANK1 KCNH2 SRGAP1 PHACTR4 FGD5 ULK1 BAIAP2 ZNF598 C2orf49 SAP130 PRRC2A CNOT4 GOLGA3	3.81e-06	1256	137	24	int:YWHAE
Interaction	ALG13 interactions	FBRS C15orf39 PRR12 NCOR2 KMT2D TNRC6A RBM6 RERE PRRC2A	4.55e-06	183	137	9	int:ALG13
Interaction	TLX3 interactions	FBRS MAML1 C15orf39 CIC ZNF503 PRR12 KMT2C NCOR2 KMT2D RERE TOX2	4.98e-06	291	137	11	int:TLX3
Interaction	BAG2 interactions	MAP1B OTUD5 MAP3K14 PPP1R13B C15orf39 TEP1 CBL WNK1 CIC ZNF503 YEATS2 SALL2 KCNH2 PHACTR4 POC5 ZNF598	5.21e-06	622	137	16	int:BAG2
Interaction	HDAC1 interactions	EHBP1 KMT2B ZCCHC8 FBRS C15orf39 TPRX2 DCTN1 CIC CASZ1 YEATS2 NCOR2 KMT2D ARID5B TNRC6A MKI67 TNKS1BP1 RERE SAP130 MNT GOLGA3 RAI1 RAD9A	5.59e-06	1108	137	22	int:HDAC1
Interaction	EYA4 interactions	BICRA FBRS MAML1 C15orf39 CIC ZNF503 PRR12 NCOR2 TNRC6A CNOT4	6.49e-06	243	137	10	int:EYA4
Interaction	GCM1 interactions	CIC ZNF503 PRR12 KMT2C NCOR2 KMT2D	6.85e-06	68	137	6	int:GCM1
Interaction	SOX6 interactions	FBRS MAML1 C15orf39 CIC ZNF503 NCOR2 SAP130 PRRC2A	1.21e-05	157	137	8	int:SOX6
Interaction	TNRC6A interactions	KMT2B MED14 MED1 WNK1 KMT2C TNRC6A TNKS1BP1 PRRC2A CNOT4 AFF4	2.22e-05	280	137	10	int:TNRC6A
Interaction	TERF2IP interactions	KMT2B ZCCHC8 MED1 SRCAP CIC YEATS2 NCOR2 SALL2 MKI67 SUGP1 SAP130 AFF4 RAI1 CBX2	2.45e-05	552	137	14	int:TERF2IP
Interaction	SOWAHA interactions	FBRS C15orf39 POM121C POM121	3.18e-05	27	137	4	int:SOWAHA
Interaction	WWTR1 interactions	MAP1B PPP1R13B SRCAP CBL DCTN1 GGA3 YEATS2 KMT2D PHACTR4 TNKS1BP1 ZNF598 PRRC2A	3.20e-05	422	137	12	int:WWTR1
Interaction	FOXI1 interactions	FBRS ZNF503 PRR12 KMT2C NCOR2 KMT2D	3.90e-05	92	137	6	int:FOXI1
Interaction	PAX6 interactions	SOX10 BICRA FBRS SRCAP CIC ZNF503 PRR12 KMT2C NCOR2 KMT2D SAP130	4.20e-05	366	137	11	int:PAX6
Interaction	SOX17 interactions	FBRS CIC PRR12 KMT2C NCOR2 KMT2D	4.68e-05	95	137	6	int:SOX17
Interaction	LMO2 interactions	NDOR1 KMT2B MED14 TSC1 ATG2A PHC2 YEATS2 EIF4EBP1 PAX9 RAI1	5.26e-05	310	137	10	int:LMO2
Interaction	KLF5 interactions	MAML1 CIC PRR12 KMT2C NCOR2 KMT2D RBM6 PRRC2A	5.74e-05	195	137	8	int:KLF5
Interaction	KIAA0408 interactions	ABI1 NDOR1 MAP1A DCTN1 RBM6	5.91e-05	61	137	5	int:KIAA0408
Interaction	FBXO42 interactions	DOCK4 MAP1A ZCCHC8 TSC1 WNK1 YEATS2 NCOR2 TNRC6A TNKS1BP1	7.13e-05	259	137	9	int:FBXO42
Interaction	YWHAZ interactions	ABI1 SEC24A COBLL1 HECTD4 ARHGEF18 TSC1 CBL WNK1 DCTN1 CIC KANK1 ASXL3 SRGAP1 FHOD1 PHACTR4 FOXO4 ULK1 BAIAP2 ZNF598 C2orf49 PRRC2A GOLGA3	8.03e-05	1319	137	22	int:YWHAZ
Interaction	CPVL interactions	PPP1R13B TSC1 DCTN1 CIC PHC2 TNRC6A PAX9	9.65e-05	156	137	7	int:CPVL
Interaction	ARHGAP12 interactions	ABI1 MUC5B PRR12 SHANK2 PHACTR4	9.97e-05	68	137	5	int:ARHGAP12
Interaction	EZR interactions	EHBP1 ABI1 COBLL1 SHC1 TSC1 FCHO2 CBL ARHGEF15 YEATS2 PHACTR4 TNKS1BP1 TRAPPC9 GOLGA3	1.04e-04	553	137	13	int:EZR
Interaction	YWHAG interactions	DOCK4 EHBP1 ABI1 SEC24A COBLL1 HECTD4 SHC1 TSC1 CBL ARHGEF17 WNK1 CIC KANK1 SRGAP1 PHACTR4 FOXO4 ULK1 BAIAP2 C2orf49 TRAPPC9 CNOT4	1.05e-04	1248	137	21	int:YWHAG
Interaction	NR3C1 interactions	FBRS MAML1 MED14 MUC16 MED1 CBL POM121C CIC CASZ1 YEATS2 NCOR2 KMT2D ASXL3 ARID5B SUGP1 FGD5 RAI1 RAD9A	1.09e-04	974	137	18	int:NR3C1
Interaction	PAX8 interactions	MAML1 CIC PRR12 KMT2C NCOR2 KMT2D	1.12e-04	111	137	6	int:PAX8
Interaction	EPHB2 interactions	EHBP1 ABI1 SEC24A PPP1R13B FCHO2 ARHGEF15 PHACTR4 BAIAP2	1.17e-04	216	137	8	int:EPHB2
Interaction	GRB2 interactions	DOCK4 WIPF1 MAP1A MAP1B OTUD5 INPP5D WIPF3 SHC1 CBL DCTN1 PHC2 NEFH FHOD1 PHACTR4 REPS2 PRRC2A	1.19e-04	806	137	16	int:GRB2
Interaction	ACTB interactions	ABI1 MAP1A MAP1B COBLL1 WIPF3 SHC1 NAA80 CC2D1A SRCAP CBL DCTN1 YEATS2 INF2 FHOD1 PHACTR4 TNKS1BP1 FGD5 BAIAP2 SAP130	1.36e-04	1083	137	19	int:ACTB
Interaction	GOLGA2 interactions	BICRA TSC1 CIC CASZ1 PRR12 SELENOV NCOR2 KMT2D SALL2 POM121 SAP130 GOLGA3 INPP5J AFF4 RAI1	1.42e-04	733	137	15	int:GOLGA2
Interaction	RET interactions	ZCCHC8 SEC24A SHC1 CBL GGA3 SHANK2 PHACTR4 BAIAP2 GOLGA3	1.44e-04	284	137	9	int:RET
Interaction	FOXK2 interactions	MAP1B CIC NCOR2 KMT2D INF2 ASXL3 SAP130 MNT	1.55e-04	225	137	8	int:FOXK2
Interaction	KMT2D interactions	SOX10 KMT2B TPRX2 KMT2C KMT2D MKI67 PAX9	1.59e-04	169	137	7	int:KMT2D
Interaction	SETD1B interactions	KMT2B YEATS2 KMT2C KMT2D RERE	1.59e-04	75	137	5	int:SETD1B
Interaction	KLF15 interactions	FBRS MAML1 CIC PRR12 KMT2C NCOR2 KMT2D SAP130 PRRC2A	1.68e-04	290	137	9	int:KLF15
Interaction	YWHAB interactions	DOCK4 ZCCHC8 SEC24A COBLL1 HECTD4 TSC1 CBL ARHGEF17 WNK1 DCTN1 CIC KANK1 SRGAP1 PHACTR4 FOXO4 BAIAP2 SAP130 CNOT4	1.79e-04	1014	137	18	int:YWHAB
Interaction	HCFC1 interactions	KMT2B CIC YEATS2 KMT2C KMT2D ASXL3 MKI67 RERE MBD5	1.81e-04	293	137	9	int:HCFC1
Interaction	TEAD1 interactions	CIC PRR12 KMT2C NCOR2 KMT2D ARID5B CBX2	2.04e-04	176	137	7	int:TEAD1
Interaction	MEN1 interactions	KMT2B ZCCHC8 MED14 MED1 SRCAP POM121C ARHGEF17 DCTN1 PRR12 KMT2C FOXB1 KMT2D MKI67 TNKS1BP1 RERE SAP130 PRRC2A AFF4	2.14e-04	1029	137	18	int:MEN1
Interaction	ZFPL1 interactions	EHBP1 ABI1 SEC24A PPP1R13B FCHO2 SLC4A2 GGA3 PHACTR4 TNKS1BP1 BAIAP2 GOLGA3	2.49e-04	448	137	11	int:ZFPL1
Interaction	DLG4 interactions	DOCK4 ABI1 NDOR1 MAP1A TSC1 PRR16 NEFH SHANK2 KCNJ4 BAIAP2 GRIN3B	2.54e-04	449	137	11	int:DLG4
Interaction	SYNGAP1 interactions	MAP1A MAP1B TSC1 FCHO2 SHANK2 SRGAP1 NCAN ULK1 BAIAP2	2.56e-04	307	137	9	int:SYNGAP1
Interaction	KMT2B interactions	KMT2B YEATS2 KMT2C KMT2D TNRC6A RERE	2.64e-04	130	137	6	int:KMT2B
Interaction	HDAC2 interactions	WNK1 DCTN1 CIC CASZ1 PHC2 NCOR2 INF2 ARID5B MKI67 SUGP1 TNKS1BP1 RERE ZNF598 SAP130 CNOT4 RAI1	2.66e-04	865	137	16	int:HDAC2
Interaction	PAX2 interactions	CIC PRR12 KMT2C NCOR2 KMT2D	2.86e-04	85	137	5	int:PAX2
Interaction	CXXC1 interactions	KMT2B YEATS2 KMT2C KMT2D MKI67 RERE	2.87e-04	132	137	6	int:CXXC1
Interaction	YTHDF2 interactions	MAP3K14 DCTN1 CIC TNRC6A MKI67 TNKS1BP1 ZNF598 PRRC2A CNOT4	2.89e-04	312	137	9	int:YTHDF2
Interaction	FGFR4 interactions	EHBP1 SEC24A SHC1 CC2D1A TSC1 FCHO2 CBL GGA3 PHACTR4 ULK1 BAIAP2	3.01e-04	458	137	11	int:FGFR4
Interaction	NFIA interactions	SOX10 MAML1 CIC PRR12 NCOR2 KMT2D PAX9	3.05e-04	188	137	7	int:NFIA
Interaction	KMT2C interactions	KMT2B KMT2C KMT2D ASXL3 TNRC6A PAX9	3.11e-04	134	137	6	int:KMT2C
Interaction	BICD1 interactions	DOCK4 ARHGEF18 CC2D1A DCTN1 GGA3 TNRC6A POC5 CNOT4	3.17e-04	250	137	8	int:BICD1
Interaction	EPS8 interactions	ABI1 SHC1 CBL SRGAP1 BAIAP2 INPP5J	3.37e-04	136	137	6	int:EPS8
Interaction	SMG7 interactions	MAML1 PRR12 YEATS2 NCOR2 KMT2D SALL2 TNRC6A RBM6 PRRC2A	3.39e-04	319	137	9	int:SMG7
Interaction	IGF1R interactions	EHBP1 SEC24A SHC1 TSC1 FCHO2 CBL GGA3 INF2 PHACTR4 FGD5 TRAPPC9	3.54e-04	467	137	11	int:IGF1R
Interaction	FGFR1 interactions	EHBP1 ABI1 SEC24A COBLL1 SHC1 PPP1R13B CC2D1A FCHO2 GGA3 PHACTR4 BAIAP2 TRAPPC9 GOLGA3	3.82e-04	632	137	13	int:FGFR1
Interaction	FOXL1 interactions	CIC ZNF503 PRR12 KMT2C NCOR2 KMT2D ARID5B	3.92e-04	196	137	7	int:FOXL1
Interaction	PRMT2 interactions	C15orf39 SALL2 POM121 FHOD1 PRRC2A	3.93e-04	91	137	5	int:PRMT2
Interaction	HOMER3 interactions	ABI1 WIPF1 TSC1 POM121 MSS51 TOX2	3.94e-04	140	137	6	int:HOMER3
Interaction	CNOT7 interactions	CBL TNRC6A MKI67 TNKS1BP1 PRRC2A CNOT4	3.94e-04	140	137	6	int:CNOT7
Interaction	PAGR1 interactions	KMT2B TPRX2 KMT2C KMT2D	3.99e-04	51	137	4	int:PAGR1
Interaction	LYN interactions	EHBP1 ABI1 INPP5D COBLL1 DUSP4 SHC1 PPP1R13B FCHO2 CBL PHACTR4 TNKS1BP1 IGSF9B ULK1 BAIAP2	3.99e-04	720	137	14	int:LYN
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	KMT2B KMT5C KMT2C KMT2D	2.70e-05	34	93	4	487
GeneFamily	Sterile alpha motif domain containing	PPFIA4 DGKH PHC2 SHANK2 CASKIN1	9.04e-05	88	93	5	760
GeneFamily	Ataxins\|Trinucleotide repeat containing	NCOR2 KMT2D TNRC6A	2.79e-04	25	93	3	775
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGEF18 ARHGEF17 ARHGEF15 FGD5	3.71e-04	66	93	4	722
GeneFamily	Netrins	NTN3 NTN1	3.87e-04	6	93	2	661
GeneFamily	Forkhead boxes	FOXB2 FOXB1 FOXO4	1.40e-03	43	93	3	508
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	MAP1B PPP1R13B WNK1 PHACTR4 MKI67	2.43e-03	181	93	5	694
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL	SOX10 MAP1B SEC24A DUSP4 MUC16 DGKH MUC5B ATG2A SERTAD4-AS1 CASZ1 SELENOV SRGAP1 RIN2 EIF4EBP3 NTN1 FGD5 PAX9 REPS2 ZNF598 SECTM1	3.62e-09	775	136	20	M45713
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	DOCK4 MAP1B PPFIA4 DUSP4 HCN3 NUTM2A VWCE CASZ1 SHANK2 ASXL3 SRGAP1 CASKIN1 NCAN TNRC6A ZFHX2 IGSF9B TOX2 GOLGA3 RAI1	4.58e-06	1106	136	19	M39071
Coexpression	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN	MAP1A MUC16 CC2D1A CIC NEFH CD8A KCNJ4 PRRC2A	1.02e-05	200	136	8	M8039
Coexpression	GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP	DOCK4 DCTN1 RIN2 RERE TOX2 MNT CNOT4 CBX2	1.02e-05	200	136	8	M6629
Coexpression	FIRESTEIN_CTNNB1_PATHWAY	MAP3K14 DGKH FOXO4 ULK1	2.23e-05	32	136	4	M1489
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	DOCK4 PPRC1 MAML1 PHC2 KANK1 ARID5B MKI67 MNT CNOT4	2.81e-05	300	136	9	M8702
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL	MAP1B DUSP4 MUC16 DGKH MUC5B SRGAP1 NTN1 PAX9 FYB2	2.89e-05	301	136	9	M45708
Coexpression	CUI_TCF21_TARGETS_2_DN	DOCK4 WIPF3 PPP1R13B ARHGEF18 DGKH CBL ARHGEF15 KMT2C KANK1 INF2 RIN2 ARID5B FGD5 MBD5 GOLGA3	3.89e-05	854	136	15	M1533
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	KMT2B WNK1 YEATS2 KMT2C PHACTR4 ULK1 TOX2	4.44e-05	180	136	7	M8239
Coexpression	RAPA_EARLY_UP.V1_DN	SOX10 MAP1A COBLL1 ATG2A WNK1 EIF4EBP1 INPP5J	5.47e-05	186	136	7	M2643
Coexpression	CUI_TCF21_TARGETS_2_DN	DOCK4 WIPF3 PPP1R13B ARHGEF18 DGKH CBL ARHGEF15 KMT2C KANK1 INF2 RIN2 ARID5B FGD5 MBD5 GOLGA3	6.04e-05	888	136	15	MM1018
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	CTC1 BICRA KATNB1 C15orf39 ATG2A ADAM8 CASZ1 GGA3 ZNF503 PHACTR4 SUGP1 ULK1 ZNF598 MNT RAI1	7.47e-05	905	136	15	M40865
Coexpression	GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN	MAP3K14 ADAM8 GGA3 NCOR2 KANK1 RIN2 BAIAP2	8.36e-05	199	136	7	M7651
Coexpression	GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP	HCN3 NAA80 CIC CD8A KCNH2 FOXO4 RAI1	8.36e-05	199	136	7	M8538
Coexpression	GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_UP	COBLL1 KATNB1 DGKH SRCAP ARHGEF15 PHACTR4 SUGP1	8.63e-05	200	136	7	M6398
Coexpression	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP	FCHO2 NCOR2 KMT2D RIN2 FOXO4 RERE REPS2	8.63e-05	200	136	7	M8050
Coexpression	GSE13306_TREG_RA_VS_TCONV_RA_UP	MAP1B SHC1 CBL REPS2 MBD5 RAD9A SECTM1	8.63e-05	200	136	7	M3226
Coexpression	GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_DN	BICRA KMT5C INPP5D ARHGEF18 CBL FOXO4 RERE	8.63e-05	200	136	7	M9733
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	COBLL1 WNK1 KANK1 TNRC6A RERE MBD5 TRAPPC9	1.10e-04	208	136	7	M39233
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DOCK4 EHBP1 ABI1 MAP1B SEC24A DUSP4 MAP3K14 MED1 NCOR2 RIN2 ARID5B RBM6 MNT CNOT4	1.51e-04	856	136	14	M4500
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	MAP1B DUSP4 HCN3 CASZ1 SHANK2 ASXL3 CASKIN1 NCAN ZFHX2 TOX2	1.63e-04	465	136	10	M39066
Coexpression	PEREZ_TP53_TARGETS	DOCK4 ZCCHC8 INPP5D MAP3K14 HECTD4 WIPF3 MAML1 EMILIN2 FCHO2 VWCE ARHGEF17 NTN1 FGD5 ULK1 BAIAP2 TOX2 FYB2	1.66e-04	1201	136	17	M4391
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 DGKH MUC5B CASZ1 SRGAP1 ULK1 MNT AFF4 RAI1	5.03e-09	179	138	9	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	Bronchial-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SOX10 DUSP4 WIPF3 MUC16 MUC5B CASZ1 SHANK2 SRGAP1 PAX9	1.32e-08	200	138	9	85c0f038bcfb42669dca2b80273b0f8a1421405e
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	HCN3 CASZ1 NEFH KCNH2 TNRC6A TOX2 INPP5J	3.56e-07	145	138	7	8b13b576fd2e6e33ccb146860a91a53cee0cdd4d
ToppCell	severe-unassigned\|World / disease stage, cell group and cell class	LETM2 BICRA DUSP4 SRCAP FOXB1 TOX2 MNT	8.16e-07	164	138	7	b3a45c150df6594debeeca400cc58d30ef662756
ToppCell	severe-unassigned\|severe / disease stage, cell group and cell class	LETM2 BICRA MAP3K14 SRCAP FOXB1 TOX2 MNT	8.50e-07	165	138	7	f9ddd547992fec065d539a1d0305acba8fc7d79c
ToppCell	COVID-19_Mild-Neu_3\|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients	EHBP1 MAP1A SEC24A COBLL1 KMT2D FHOD1 GOLGA3	1.31e-06	176	138	7	2049767fd591045cfcf5b1071d80798e52843f27
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DOCK4 COBLL1 CASZ1 ARHGEF15 RIN2 FGD5 TOX2	2.18e-06	190	138	7	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	MS-Treg-exh_CD4\|MS / Condition, Cell_class and T cell subcluster	OTUD5 DUSP4 TSC1 DCTN1 NUFIP1 INF2 TOX2	2.34e-06	192	138	7	c6722bf142c84ccedd99c1a3344085aecb4cbab4
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	KANK1 SHANK2 TNRC6A RBM6 RERE MBD5 TRAPPC9	2.34e-06	192	138	7	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1B SHC1 SRCAP POM121C SLC4A2 POM121 TNKS1BP1	2.96e-06	199	138	7	85bb28369e0568b7b3bda095722102fc793f60ef
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	KMT2C SHANK2 TNRC6A RBM6 RERE MBD5 TRAPPC9	2.96e-06	199	138	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	ABI1 FCHO2 MED1 DCTN1 CIC SLC4A2 NCOR2	3.06e-06	200	138	7	1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 PPP1R13B MUC5B CASZ1 SHANK2 SRGAP1 PAX9	3.06e-06	200	138	7	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC16 MUC5B SHANK2 NTN1 PAX9 FYB2	1.11e-05	161	138	6	2d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell	Adult-Epithelial-lung_goblet_cell-D231\|Adult / Lineage, Cell type, age group and donor	MUC16 MUC5B ASXL3 NTN1 PAX9 FYB2	1.73e-05	174	138	6	7d2f802f493f19a068e097b2909a9000e2160266
ToppCell	Fetal_29-31_weeks-Epithelial-lung_goblet_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	WIPF3 MUC16 MUC5B NTN1 PAX9 FYB2	1.90e-05	177	138	6	a4c001a8e44142babf9f24dfe6f7b73a70b11b16
ToppCell	Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	WIPF3 MUC16 MUC5B NTN1 PAX9 FYB2	1.90e-05	177	138	6	363e07b0f347f3716d530a28ead854b98e27d37c
ToppCell	droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK4 DGKH FCHO2 ARHGEF15 LIPE FGD5	2.23e-05	182	138	6	81279877b920b5a1bc991a07d3031d6458700fe3
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC16 MUC5B SHANK2 NTN1 PAX9 FYB2	2.23e-05	182	138	6	3f1a666fe27dd7529c114539ed5f6b8ca585c875
ToppCell	Epithelial-lung_goblet_cell\|World / Lineage, Cell type, age group and donor	MUC16 MUC5B SHANK2 NTN1 PAX9 FYB2	2.30e-05	183	138	6	940cbe298e9c53b5622af09264586ed823d3141f
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_3\|390C / Donor, Lineage, Cell class and subclass (all cells)	OTUD5 DUSP4 FHOD1 PHACTR4 FOXO4 C2orf49	2.30e-05	183	138	6	228092290dbb08785c4eda224e3ad03e99e10fab
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PPFIA4 INPP5D DUSP4 CD8A MKI67 PRR11	2.37e-05	184	138	6	8260e688ec42a1374727bc85dceb7edd19a8b662
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	MUC16 MUC5B SHANK2 NTN1 PAX9 FYB2	2.84e-05	190	138	6	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	Substantia_nigra\|World / BrainAtlas - Mouse McCarroll V32	VWCE ZNF503 FOXB1 XIRP2 NTN1	2.96e-05	115	138	5	18174b8d57d444fab1e9d2b13d22939c83c958e0
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	EHBP1 WNK1 TNRC6A RERE MBD5 AFF4	3.01e-05	192	138	6	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	GLB1L3 DUSP4 MUC5B SRGAP1 NTN1 PAX9	3.01e-05	192	138	6	5d24bb6c6c17a6b803b241d065b31896a7d86c37
ToppCell	390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	GLB1L3 DUSP4 MUC5B SRGAP1 NTN1 PAX9	3.01e-05	192	138	6	c6795ceba90f1a5d441dff92a737b9c7d28b06b0
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	EHBP1 WNK1 TNRC6A RERE MBD5 AFF4	3.10e-05	193	138	6	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	CTRL-Myeloid-Monocyte_Macrophage\|Myeloid / Disease state, Lineage and Cell class	DOCK4 DUSP4 ADAM8 PRR16 SRGAP1 ARID5B	3.19e-05	194	138	6	73459ee062ae1f1a3bb9719dc0b89aae10600e22
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK4 KANK1 SHANK2 RERE MBD5 TRAPPC9	3.38e-05	196	138	6	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK4 KANK1 SHANK2 RERE MBD5 TRAPPC9	3.57e-05	198	138	6	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1B SHC1 SRCAP POM121C ARHGEF17 POM121	3.57e-05	198	138	6	399760b6b6fef8639ded53b14f251b9fce600e81
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Intermediate\|10w / Sample Type, Dataset, Time_group, and Cell type.	DUSP4 ARHGEF18 CASZ1 ZNF503 ALPK3 NTN1	3.78e-05	200	138	6	e5a8647c47a49c8c90c78d681193946de103d8ff
Drug	PHA-00745360 [351320-33-7]; Down 200; 1uM; MCF7; HT_HG-U133A	KMT2B NAA80 CBL CD8A SHANK2 ZFHX2 RERE CNOT4 INPP5J SECTM1	2.68e-07	194	136	10	3910_DN
Drug	Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A	PPFIA4 COBLL1 SRCAP NCOR2 SHANK2 KCNH2 SUGP1 NTN1 RERE SECTM1	2.81e-07	195	136	10	4105_UP
Drug	Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; HL60; HT_HG-U133A	SOX10 MAP1B CTC1 BICRA SRCAP ADAM8 CASZ1 KANK1 CNOT4 AFF4	2.81e-07	195	136	10	3124_UP
Drug	Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A	NDOR1 WIPF1 MAP1A DUSP4 NAA80 MUC5B TEP1 GGA3 SUGP1 RERE	2.95e-07	196	136	10	3360_UP
Drug	Merbromin [129-16-8]; Down 200; 5uM; MCF7; HT_HG-U133A	BICRA COBLL1 DUSP4 C15orf39 CC2D1A TEP1 ADAM8 SUGP1 BAIAP2 INPP5J	3.09e-07	197	136	10	3439_DN
Drug	Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A	KMT2B MAP1B MED14 SRCAP NCOR2 RIN2 SUGP1 BAIAP2 AFF4	2.59e-06	194	136	9	7164_UP
Drug	CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A	KATNB1 NAA80 SRCAP ARHGEF17 WNK1 ADAM8 GGA3 SUGP1 AFF4	2.71e-06	195	136	9	3909_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	NDOR1 WIPF1 COBLL1 NAA80 SRCAP ARHGEF17 CIC KCNH2 SUGP1	2.71e-06	195	136	9	4180_DN
Drug	6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A	DOCK4 MAP1A MED14 NAA80 SRCAP WNK1 CD8A SUGP1 TRAPPC9	2.82e-06	196	136	9	7346_UP
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	MAP1A C15orf39 SRCAP ARHGEF17 GGA3 FHOD1 PRRC2A GOLGA3 INPP5J	3.07e-06	198	136	9	7035_UP
Drug	genistein; Up 200; 10uM; HL60; HT_HG-U133A	DOCK4 SEC24A DUSP4 MED14 KMT2D SUGP1 NTN1 FOXO4	1.85e-05	189	136	8	2695_UP
Drug	Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; MCF7; HT_HG-U133A	COBLL1 DUSP4 CBL ARHGEF17 GGA3 YEATS2 CD8A KCNH2	2.15e-05	193	136	8	4146_DN
Drug	2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A	MAP1A MAP1B COBLL1 SRCAP CIC CASZ1 SALL2 NCAN	2.15e-05	193	136	8	5600_UP
Drug	Trifluridine [70-00-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A	KATNB1 FBRS MED14 TEP1 KCNH2 RIN2 BAIAP2 CNOT4	2.15e-05	193	136	8	7176_UP
Drug	Retrorsine [480-54-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A	WIPF1 FBRS CBL KCNH2 FHOD1 BAIAP2 INPP5J AFF4	2.23e-05	194	136	8	2784_DN
Drug	estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A	FBRS SRCAP TEP1 ARHGEF17 ADAM8 GGA3 KCNH2 ZFHX2	2.40e-05	196	136	8	5568_DN
Drug	Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; MCF7; HT_HG-U133A	DUSP4 NAA80 MUC5B SRCAP ARHGEF17 SUGP1 BAIAP2 TRAPPC9	2.40e-05	196	136	8	4416_DN
Drug	Methiazole; Down 200; 15uM; MCF7; HT_HG-U133A	CTC1 SRCAP CBL ARHGEF17 ADAM8 NCOR2 CD8A SUGP1	2.40e-05	196	136	8	3878_DN
Drug	Doxepin hydrochloride [1229-29-4]; Down 200; 12.6uM; HL60; HT_HG-U133A	NAA80 CC2D1A WNK1 ADAM8 CIC INF2 SUGP1 TRAPPC9	2.49e-05	197	136	8	2384_DN
Drug	Sulfaguanidine [57-67-0]; Up 200; 18.6uM; MCF7; HT_HG-U133A	SOX10 NDOR1 MAP1A KCNH2 NCAN SUGP1 RERE SECTM1	2.58e-05	198	136	8	4839_UP
Drug	Cisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A	KATNB1 FBRS SRCAP TEP1 WNK1 CIC RIN2 BAIAP2	2.58e-05	198	136	8	3305_DN
Drug	Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A	KMT2B COBLL1 MUC5B TEP1 WNK1 INF2 ULK1 PRRC2A	2.58e-05	198	136	8	4592_DN
Drug	Trapidil [15421-84-8]; Down 200; 19.4uM; MCF7; HT_HG-U133A	DOCK4 MAP1A KCNH2 PHACTR4 SUGP1 ZFHX2 BAIAP2 SECTM1	2.58e-05	198	136	8	6515_DN
Drug	Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; HL60; HT_HG-U133A	MAP1B DUSP4 CC2D1A GGA3 SUGP1 NTN1 REPS2 INPP5J	2.68e-05	199	136	8	2936_UP
Drug	Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A	NDOR1 MAP1B SRCAP SALL2 CD8A KCNH2 SUGP1 INPP5J	2.68e-05	199	136	8	6033_DN
Drug	Dimaprit dihydrochloride [23256-33-9]; Down 200; 17uM; MCF7; HT_HG-U133A	COBLL1 FBRS MED14 KCNH2 RIN2 ZFHX2 TRAPPC9 INPP5J	2.78e-05	200	136	8	6520_DN
Drug	Niclosamide [50-65-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A	MAP1B DUSP4 SRCAP NCOR2 ULK1 RERE MNT	4.68e-05	158	136	7	4136_UP
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; HL60; HT_HG-U133A	SEC24A FBRS MAML1 ATG2A ARID5B MKI67 CNOT4	7.17e-05	169	136	7	2193_UP
Drug	Tribenoside [10310-32-4]; Up 200; 8.4uM; HL60; HT_HG-U133A	CTC1 DUSP4 FBRS MED14 CASZ1 SHANK2 TRAPPC9	1.22e-04	184	136	7	2946_UP
Drug	fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	DUSP4 CASZ1 SUGP1 ULK1 BAIAP2 CNOT4 SECTM1	1.35e-04	187	136	7	1662_UP
Drug	Triflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A	BICRA DUSP4 TEP1 CBL KCNH2 SUGP1 BAIAP2	1.39e-04	188	136	7	7466_UP
Drug	Fenbendazole [43210-67-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A	MAP1A MAP1B DUSP4 CC2D1A SRCAP GGA3 CD8A	1.49e-04	190	136	7	3888_UP
Drug	Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A	EHBP1 MAP1B CTC1 MED1 TEP1 WNK1 CNOT4	1.49e-04	190	136	7	4307_DN
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	COBLL1 MAML1 MUC5B SRCAP SHANK2 PAX9 CNOT4	1.54e-04	191	136	7	3975_DN
Drug	Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A	BICRA KATNB1 SRCAP ADAM8 KCNH2 SUGP1 SECTM1	1.59e-04	192	136	7	2271_DN
Drug	Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA	MAP1B PPRC1 BICRA CC2D1A NCOR2 SHANK2 FHOD1	1.64e-04	193	136	7	948_UP
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	MAML1 MED1 SRCAP CIC SUGP1 BAIAP2 SECTM1	1.64e-04	193	136	7	5239_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A	DUSP4 MUC5B SRCAP TEP1 CIC SUGP1 RERE	1.69e-04	194	136	7	3969_DN
Drug	Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A	C15orf39 SRCAP WNK1 KCNH2 RIN2 BAIAP2 INPP5J	1.69e-04	194	136	7	2792_DN
Drug	Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; MCF7; HT_HG-U133A	WIPF1 KATNB1 C15orf39 SRCAP CIC SUGP1 INPP5J	1.69e-04	194	136	7	2831_DN
Drug	Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A	COBLL1 ATG2A CIC SALL2 INF2 KCNH2 AFF4	1.69e-04	194	136	7	7354_DN
Drug	Propantheline bromide [50-34-0]; Up 200; 9uM; MCF7; HT_HG-U133A	SEC24A NAA80 TEP1 KCNH2 PHACTR4 BAIAP2 TRAPPC9	1.69e-04	194	136	7	4798_UP
Drug	5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA	MAP1A DUSP4 SRCAP ADAM8 KCNH2 BAIAP2 REPS2	1.69e-04	194	136	7	828_UP
Drug	Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; MCF7; HT_HG-U133A	WIPF1 CTC1 MAML1 NAA80 SRCAP TEP1 SHANK2	1.75e-04	195	136	7	4972_UP
Drug	17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A	KATNB1 MAP3K14 ARHGEF17 SHANK2 RIN2 BAIAP2 CNOT4	1.75e-04	195	136	7	1650_UP
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; PC3; HT_HG-U133A	KMT2B MAP1A MAP1B CC2D1A DCTN1 RERE REPS2	1.75e-04	195	136	7	5117_DN
Drug	Iodixanol [92339-11-2]; Up 200; 2.6uM; MCF7; HT_HG-U133A	WIPF1 COBLL1 DUSP4 NAA80 WNK1 SALL2 PAX9	1.75e-04	195	136	7	4848_UP
Drug	SR-95639A [115767-94-7]; Down 200; 10uM; HL60; HT_HG-U133A	DUSP4 MAML1 CC2D1A CIC GGA3 INF2 CNOT4	1.75e-04	195	136	7	1336_DN
Drug	Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A	KATNB1 MUC5B SRCAP CBL GGA3 FHOD1 CNOT4	1.75e-04	195	136	7	2875_UP
Drug	Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; HL60; HT_HG-U133A	CBL WNK1 DCTN1 KANK1 INF2 FOXO4 TRAPPC9	1.75e-04	195	136	7	1298_UP
Drug	5-(2-chlorophenyl)-2-furoic acid	MAP1B TSC1 NEFH EIF4EBP1	1.78e-04	47	136	4	CID000784625
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A	DOCK4 BICRA CC2D1A ADAM8 SLC4A2 ARID5B SUGP1	1.80e-04	196	136	7	2035_UP
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	DOCK4 KATNB1 FBRS DCTN1 CASZ1 SUGP1 PRRC2A	1.80e-04	196	136	7	4834_DN
Drug	Sulindac [38194-50-2]; Down 200; 11.2uM; HL60; HT_HG-U133A	DOCK4 ZCCHC8 SEC24A CC2D1A CIC ULK1 RERE	1.80e-04	196	136	7	1857_DN
Drug	Ribavirin [36791-04-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A	MAP1A SEC24A SRCAP GGA3 SUGP1 BAIAP2 PAX9	1.80e-04	196	136	7	6018_UP
Drug	Trichlorfon [52-68-6]; Up 200; 15.6uM; MCF7; HT_HG-U133A	MAP1A CC2D1A KMT2D SUGP1 PAX9 AFF4 SECTM1	1.80e-04	196	136	7	5989_UP
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; HL60; HT_HG-U133A	ADAM8 DCTN1 CIC SLC4A2 FHOD1 SUGP1 CNOT4	1.80e-04	196	136	7	2361_DN
Drug	Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; HL60; HT_HG-U133A	PPRC1 PPFIA4 FBRS SRCAP INF2 CNOT4 RAD9A	1.80e-04	196	136	7	2936_DN
Drug	Fenbendazole [43210-67-9]; Down 200; 13.4uM; HL60; HT_HG-U133A	BICRA NAA80 YEATS2 PHACTR4 SUGP1 TRAPPC9 CNOT4	1.80e-04	196	136	7	2360_DN
Drug	Cortisone [53-06-5]; Up 200; 11uM; MCF7; HT_HG-U133A	KATNB1 MED14 SRCAP CBL SUGP1 RERE SECTM1	1.86e-04	197	136	7	7458_UP
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; HL60; HT_HG-U133A	INPP5D CBL ARID5B MKI67 SUGP1 ULK1 CNOT4	1.86e-04	197	136	7	2547_DN
Drug	Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A	MAP1B NAA80 SRCAP ADAM8 GGA3 NEFH CBX2	1.86e-04	197	136	7	2324_UP
Drug	Suprofen [40828-46-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	KMT2B MAP1B KATNB1 FBRS ATG2A SUGP1 ZFHX2	1.86e-04	197	136	7	3343_DN
Drug	Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HG-U133A	CC2D1A MED1 ADAM8 DCTN1 SLC4A2 SALL2 SHANK2	1.86e-04	197	136	7	1941_DN
Drug	Ioversol [87771-40-2]; Down 200; 5uM; MCF7; HT_HG-U133A	MUC5B MED1 SRCAP ARHGEF17 SUGP1 RERE SECTM1	1.86e-04	197	136	7	3365_DN
Drug	Danazol [17230-88-5]; Up 200; 11.8uM; HL60; HG-U133A	MAP1A MAP1B FBRS PPP1R13B CC2D1A ZFHX2 BAIAP2	1.86e-04	197	136	7	2038_UP
Drug	Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A	LIPE SHANK2 KCNJ4 NCAN SUGP1 NTN1 PAX9	1.86e-04	197	136	7	6054_UP
Drug	Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A	MAML1 SRCAP CBL SALL2 SHANK2 SUGP1 RERE	1.86e-04	197	136	7	6787_DN
Drug	Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A	NDOR1 COBLL1 KATNB1 ARHGEF15 SUGP1 MNT INPP5J	1.86e-04	197	136	7	4299_UP
Drug	LY 294002; Down 200; 0.1uM; HL60; HT_HG-U133A	KMT2B INPP5D DUSP4 FBRS NEFH SUGP1 TRAPPC9	1.86e-04	197	136	7	1157_DN
Drug	Bethanechol chloride [590-63-6]; Down 200; 20.4uM; HL60; HT_HG-U133A	BICRA DUSP4 C15orf39 CC2D1A SRCAP SALL2 C2orf49	1.86e-04	197	136	7	2975_DN
Drug	Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A	MAP1A COBLL1 MUC5B ADAM8 NCOR2 KCNH2 RAI1	1.86e-04	197	136	7	5633_UP
Drug	alpha-estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A	PPP1R13B NAA80 TEP1 WNK1 GGA3 ALPK3 ZFHX2	1.86e-04	197	136	7	1210_UP
Drug	Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A	KMT2B CTC1 BICRA COBLL1 C15orf39 DCTN1 CIC	1.86e-04	197	136	7	1697_DN
Drug	Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; HL60; HT_HG-U133A	BICRA DUSP4 CC2D1A ADAM8 SUGP1 C2orf49 TRAPPC9	1.92e-04	198	136	7	1320_DN
Drug	estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A	BICRA DUSP4 FBRS MED14 SUGP1 BAIAP2 TRAPPC9	1.92e-04	198	136	7	6928_DN
Drug	Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; MCF7; HT_HG-U133A	KMT2B GGA3 SHANK2 KCNH2 PRRC2A INPP5J SECTM1	1.92e-04	198	136	7	1541_UP
Drug	Primidone [125-33-7]; Down 200; 18.4uM; MCF7; HT_HG-U133A	KMT2B MED1 SRCAP NCOR2 KCNH2 ZFHX2 RERE	1.92e-04	198	136	7	3402_DN
Drug	Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; PC3; HT_HG-U133A	MAP1A SRCAP TEP1 WNK1 FHOD1 SUGP1 PAX9	1.92e-04	198	136	7	5799_DN
Drug	Glycopyrrolate [596-51-0]; Down 200; 10uM; MCF7; HT_HG-U133A	FBRS ADAM8 KCNH2 RIN2 RERE TRAPPC9 AFF4	1.92e-04	198	136	7	3427_DN
Drug	Gelsemine [509-15-9]; Down 200; 12.4uM; HL60; HT_HG-U133A	DUSP4 FBRS MED14 NAA80 SRCAP INF2 CNOT4	1.92e-04	198	136	7	2162_DN
Drug	Etanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A	BICRA MAP3K14 FBRS MED14 BAIAP2 MNT TRAPPC9	1.92e-04	198	136	7	6211_DN
Drug	Chloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A	MUC5B SRCAP GGA3 INF2 RIN2 ZFHX2 CNOT4	1.92e-04	198	136	7	4414_DN
Drug	Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; PC3; HT_HG-U133A	COBLL1 NAA80 TEP1 SUGP1 ZFHX2 FOXO4 TRAPPC9	1.92e-04	198	136	7	3785_DN
Drug	Denatonium benzoate [3734-33-6]; Down 200; 9uM; MCF7; HT_HG-U133A	CTC1 COBLL1 MED14 YEATS2 KCNH2 RIN2 SECTM1	1.92e-04	198	136	7	6502_DN
Drug	Dipyrone [5907-38-0]; Up 200; 12uM; MCF7; HT_HG-U133A	SRCAP ADAM8 SHANK2 RERE INPP5J RAI1 CBX2	1.92e-04	198	136	7	3929_UP
Drug	Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; MCF7; HT_HG-U133A	MAP1A NAA80 CBL ADAM8 GGA3 RERE SECTM1	1.92e-04	198	136	7	3356_UP
Drug	Nomegestrol acetate [58652-20-3]; Down 200; 10.8uM; PC3; HT_HG-U133A	MAP1A FBRS CC2D1A SALL2 INF2 SUGP1 BAIAP2	1.92e-04	198	136	7	6362_DN
Drug	Hemicholinium bromide [312-45-8]; Down 200; 7uM; HL60; HG-U133A	NACA HECTD4 MAML1 MED1 SUGP1 RERE C2orf49	1.92e-04	198	136	7	1601_DN
Drug	Tocainide hydrochloride; Down 200; 17.4uM; MCF7; HT_HG-U133A	WIPF1 MAP1B BICRA COBLL1 ADAM8 KCNH2 SECTM1	1.92e-04	198	136	7	4838_DN
Drug	Tolazamide [1156-19-0]; Down 200; 12.8uM; MCF7; HT_HG-U133A	C15orf39 SRCAP ARHGEF17 WNK1 CIC SHANK2 SUGP1	1.92e-04	198	136	7	2842_DN
Drug	Niacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A	KMT2B MUC5B MED1 SHANK2 SUGP1 ZFHX2 SECTM1	1.98e-04	199	136	7	3381_DN
Drug	Clenbuterol hydrochloride [21898-19-1]; Up 200; 12.8uM; MCF7; HT_HG-U133A	MAML1 SRCAP CBL ADAM8 CD8A SUGP1 ZFHX2	1.98e-04	199	136	7	5266_UP
Drug	Ungerine nitrate; Up 200; 10.2uM; MCF7; HT_HG-U133A	MAP1A NAA80 SRCAP NCOR2 KCNH2 PAX9 CNOT4	1.98e-04	199	136	7	6076_UP
Drug	PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A	FBRS CC2D1A SRCAP NCOR2 INF2 SUGP1 CNOT4	1.98e-04	199	136	7	4562_DN
Drug	Nimodipine [66085-59-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A	NDOR1 COBLL1 NAA80 ARHGEF17 CIC CD8A KCNH2	1.98e-04	199	136	7	5421_DN
Drug	Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; MCF7; HT_HG-U133A	WIPF1 CTC1 FBRS ARHGEF17 CD8A KCNH2 RERE	1.98e-04	199	136	7	4982_UP
Drug	Mafenide hydrochloride [138-37-4]; Down 200; 18uM; MCF7; HT_HG-U133A	COBLL1 SRCAP CBL WNK1 SUGP1 RERE SECTM1	1.98e-04	199	136	7	2287_DN
Drug	Triflupromazine hydrochloride [1098-60-8]; Down 200; 10.2uM; PC3; HT_HG-U133A	EHBP1 MAP1B FBRS PPP1R13B SRCAP SALL2 INF2	1.98e-04	199	136	7	1813_DN
Drug	Benzthiazide [91-33-8]; Up 200; 9.2uM; HL60; HT_HG-U133A	DUSP4 MED14 KMT2D SALL2 FOXO4 RERE REPS2	2.04e-04	200	136	7	2989_UP
Disease	Kleefstra syndrome 2 (implicated_via_orthology)	KMT2C KMT2D	2.11e-05	2	136	2	DOID:0080598 (implicated_via_orthology)
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	ZCCHC8 COBLL1 EMILIN2 POM121C TNRC6A POC5 RERE BAIAP2 PRRC2A	5.07e-05	364	136	9	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	Paroxysmal atrial fibrillation	WIPF1 PPFIA4 NACA CASZ1 KCNH2 MBD5	8.85e-05	156	136	6	C0235480
Disease	familial atrial fibrillation	WIPF1 PPFIA4 NACA CASZ1 KCNH2 MBD5	8.85e-05	156	136	6	C3468561
Disease	Persistent atrial fibrillation	WIPF1 PPFIA4 NACA CASZ1 KCNH2 MBD5	8.85e-05	156	136	6	C2585653
Disease	body fat percentage	ZCCHC8 COBLL1 EMILIN2 POM121C TNRC6A POC5 IGSF9B RERE BAIAP2 PRRC2A	9.27e-05	488	136	10	EFO_0007800
Disease	Atrial Fibrillation	WIPF1 PPFIA4 NACA CASZ1 KCNH2 MBD5	1.02e-04	160	136	6	C0004238
Disease	amyotrophic lateral sclerosis type 1 (is_implicated_in)	DCTN1 NEFH	1.26e-04	4	136	2	DOID:0060193 (is_implicated_in)
Disease	AMYOTROPHIC LATERAL SCLEROSIS 1	DCTN1 NEFH	1.26e-04	4	136	2	105400
Disease	Amyotrophic lateral sclerosis type 1	DCTN1 NEFH	1.26e-04	4	136	2	cv:C1862939
Disease	tuberous sclerosis (implicated_via_orthology)	TSC1 EIF4EBP1	2.09e-04	5	136	2	DOID:13515 (implicated_via_orthology)
Disease	Antihypertensive use measurement	NACA ARHGEF18 CASZ1 PHACTR4 TNRC6A RBM6 FGD5	2.37e-04	265	136	7	EFO_0009927
Disease	congenital heart disease (implicated_via_orthology)	KMT2B KMT2C KMT2D SAP130	2.96e-04	69	136	4	DOID:1682 (implicated_via_orthology)
Disease	atrial fibrillation	WIPF1 BICRA PPFIA4 NACA CASZ1 NCOR2 KCNH2 MBD5	3.37e-04	371	136	8	EFO_0000275
Disease	metabolic syndrome	COBLL1 HECTD4 KCNH2 TNRC6A RBM6 POC5	3.41e-04	200	136	6	EFO_0000195
Disease	bitter alcoholic beverage consumption measurement	PPP1R13B SERTAD4-AS1 CIC TNRC6A IGSF9B	3.87e-04	133	136	5	EFO_0010092
Disease	Growth Disorders	CBL AFF4 RAI1	6.12e-04	36	136	3	C0018273
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	EHBP1 MAP1A COBLL1 NCOR2 NCAN SUGP1	6.19e-04	224	136	6	EFO_0004574, EFO_0008317
Disease	infection	INPP5D PRR16	7.43e-04	9	136	2	EFO_0000544
Disease	thyroid gland papillary carcinoma (is_implicated_in)	KMT2D SRGAP1	9.26e-04	10	136	2	DOID:3969 (is_implicated_in)
Disease	fish oil supplement exposure measurement, triglyceride measurement	MAP1A NCAN	9.26e-04	10	136	2	EFO_0004530, EFO_0600007
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	COBLL1 NCOR2 PMPCA SUGP1 POC5 RAI1	9.45e-04	243	136	6	EFO_0004612, EFO_0020944
Disease	liver fat measurement	NCAN SUGP1 ZFHX2	1.03e-03	43	136	3	EFO_0010821
Disease	JT interval	NACA CASZ1 KCNH2 KCNJ4 ALPK3 RAI1	1.05e-03	248	136	6	EFO_0007885
Disease	serum gamma-glutamyl transferase measurement	EHBP1 MAP1A BICRA COBLL1 HECTD4 POM121C ARHGEF15 NCOR2 POM121 ULK1 PRRC2A CNOT4	1.10e-03	914	136	12	EFO_0004532
Disease	glomerulosclerosis (implicated_via_orthology)	SHC1 INF2	1.13e-03	11	136	2	DOID:0050851 (implicated_via_orthology)
Disease	Neurobehavioral Manifestations	NTN1 RAI1	1.35e-03	12	136	2	C0525041
Disease	Amyotrophic Lateral Sclerosis, Familial	SHC1 DCTN1 NEFH	1.42e-03	48	136	3	C4551993
Disease	Amyotrophic Lateral Sclerosis, Sporadic	SHC1 DCTN1 NEFH	1.42e-03	48	136	3	C1862941
Disease	bipolar disorder	LETM2 BICRA PPP1R13B DGKH ARHGEF15 KMT2D SHANK2 NCAN IGSF9B	1.46e-03	577	136	9	MONDO_0004985
Disease	N-acetyl-isoputreanine measurement	ADAM8 KCNH2	1.59e-03	13	136	2	EFO_0800107
Disease	sphingomyelin 18:1 measurement	MAP1B TNKS1BP1	1.59e-03	13	136	2	EFO_0010394
Disease	AMYOTROPHIC LATERAL SCLEROSIS 1	SHC1 DCTN1 NEFH	1.60e-03	50	136	3	C1862939
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	ZCCHC8 SUGP1 POC5	1.70e-03	51	136	3	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	breast cancer (is_marker_for)	KMT2B TSC1 NCOR2 KMT2D MKI67	1.70e-03	185	136	5	DOID:1612 (is_marker_for)
Disease	mean arterial pressure	DUSP4 HECTD4 POM121C CASZ1 YEATS2 TNRC6A FGD5 RERE	2.26e-03	499	136	8	EFO_0006340
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	COBLL1 PMPCA ASXL3 SUGP1 POC5	2.39e-03	200	136	5	EFO_0004611, EFO_0020945
Disease	T-Cell Lymphoma	KMT2D ASXL3	2.43e-03	16	136	2	C0079772
Disease	autism spectrum disorder (is_implicated_in)	BAIAP2 MBD5	2.43e-03	16	136	2	DOID:0060041 (is_implicated_in)
Disease	cholesteryl esters to total lipids in large HDL percentage	COBLL1 NCOR2 POC5	2.58e-03	59	136	3	EFO_0022248
Disease	Amyotrophic lateral sclerosis	DCTN1 NEFH	2.74e-03	17	136	2	cv:C0002736
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B MKI67	3.25e-03	64	136	3	DOID:4947 (is_marker_for)
Disease	attention deficit hyperactivity disorder, schizophrenia	PPP1R13B ARID5B RAI1	3.25e-03	64	136	3	EFO_0003888, MONDO_0005090
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	EHBP1 COBLL1 NCOR2 NCAN SUGP1	3.26e-03	215	136	5	EFO_0008317, EFO_0008591
Disease	comparative body size at age 10, self-reported	DGKH WNK1 TNRC6A POC5 RERE BAIAP2 RAD9A	3.42e-03	420	136	7	EFO_0009819
Disease	ovulation	EIF4EBP1 PRRC2A	3.43e-03	19	136	2	GO_0030728
Disease	factor VIII measurement, Ischemic stroke	HECTD4 FCHO2	3.43e-03	19	136	2	EFO_0004630, HP_0002140
Disease	joint damage measurement	COBLL1 MAP3K14 SRGAP1	3.86e-03	68	136	3	EFO_0005413
Disease	Profound Mental Retardation	ZCCHC8 CIC SHANK2 RAI1	3.98e-03	139	136	4	C0020796
Disease	Mental Retardation, Psychosocial	ZCCHC8 CIC SHANK2 RAI1	3.98e-03	139	136	4	C0025363
Disease	Mental deficiency	ZCCHC8 CIC SHANK2 RAI1	3.98e-03	139	136	4	C0917816
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	ZCCHC8 SUGP1 POC5	4.02e-03	69	136	3	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	Bladder Neoplasm	TSC1 KMT2C KMT2D NCAN	4.08e-03	140	136	4	C0005695
Disease	ascending aortic diameter	ARID5B FGD5 MBD5 TRAPPC9	4.08e-03	140	136	4	EFO_0021787
Disease	Malignant neoplasm of urinary bladder	TSC1 KMT2C KMT2D NCAN	4.19e-03	141	136	4	C0005684
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	EHBP1 COBLL1 NCOR2 NCAN SUGP1	4.26e-03	229	136	5	EFO_0004639, EFO_0008317
Disease	lipid measurement, high density lipoprotein cholesterol measurement	MAP1A COBLL1 NCOR2 NCAN POC5 RAI1	4.36e-03	330	136	6	EFO_0004529, EFO_0004612

Protein segments in the cluster

Peptide	Gene	Start	Entry
PVKSPPLSPVGTTPV	C2orf49	186	Q9BVC5
LPPPAPPAGITRSKS	SLC4A2	486	P04920
PPAPSPLPATPLSAK	ARHGEF18	1336	Q6ZSZ5
VPVFPLTISPGPVTP	CTC1	186	Q2NKJ3
IPTPVLTSPGAVPPL	DCTN1	196	Q14203
LTSPGAVPPLPSPSK	DCTN1	201	Q14203
PAKVPPTPSLAPAPL	CASZ1	386	Q86V15
PTTPLSVGTIVPPPR	FCHO2	451	Q0JRZ9
LPQIPGVTTPPTAPL	EIF4EBP3	61	O60516
PVTKTPPRDLPTIPG	EIF4EBP1	66	Q13541
ATSLGPPSRTPKLPP	ALPK3	931	Q96L96
SIGIPIAVPTPSPPT	ABI1	256	Q8IZP0
PAASLKPPALLPPSA	ARHGEF15	66	O94989
VFLPAKPTTTPAPRP	CD8A	131	P01732
SSVALKRPPPAPPVT	ADAM8	741	P78325
PGPSPPIAVALEVKP	CACTIN-AS1	41	Q8N1I8
ASPPPIAPKPVTIPA	COBLL1	946	Q53SF7
KPVLPSGSTSPSPLP	PPP1R13B	611	Q96KQ4
PPRPPSPTEIAGQKL	ATG2A	1246	Q2TAZ0
ETRLPPPLSSKEGPP	ASXL3	1126	Q9C0F0
LLPSPAGPVPSKDPK	AFF4	811	Q9UHB7
IPSSTPGTAPPPKVL	MUC5B	3011	Q9HC84
SPIAPCIKIPVAPPT	NTN1	446	O95631
PPGLTTTPAPPDKLG	RAI1	1071	Q7Z5J4
VLPSISLSPGPQPPK	RAD9A	321	Q99638
SKITVLPAPPPPPSA	KCNJ4	356	P48050
PIPAPASPGTRPTLK	ARHGEF17	521	Q96PE2
LNPGLTKPPVPRVSP	MAML1	816	Q92585
PPSPLPVTSLLTSGP	MUC16	7711	Q8WXI7
SPSKGSEPRPLVPPV	NCOR2	1971	Q9Y618
PVTSPLLPSPPAAVG	POC5	411	Q8NA72
PPPTAPKPVKAVAGL	CASKIN1	1276	Q8WXD9
LAKPPGTPPSLGASP	CASKIN1	1311	Q8WXD9
AKVPTPPGVPAIPGS	PAX9	171	P55771
IKPTPALPPVSALQP	FOXB2	366	Q5VYV0
PITPSTPISLPKGPI	LETM2	451	Q2VYF4
PVPSPIIPILPSTAG	KMT2C	4031	Q8NEZ4
AVPPRAPILSKGPSP	MAP1A	2061	P78559
PSPPSPLEKTPLGER	MAP1B	1261	P46821
TPAPAGTPGPILIPK	KMT5C	416	Q86Y97
TIVTPVPLTPSKPGP	MSS51	26	Q4VC12
LTISPPVPSGPPSKS	NAA80	251	Q93015
SSTPIPPVPKGQVPL	ERVFC1-1	306	P60608
SVSATPLPRVPKLPP	GLB1L3	391	Q8NCI6
STLGTLQPPPAPPKK	PPFIA4	1151	O75335
PGPTSTSPLLPVSPL	KCNH2	1086	Q12809
LPRPPVVASTPAPKA	KATNB1	436	Q9BVA0
PKPLEAPGPSSLVPT	FOXO4	416	P98177
KGPGLLSPPSASPVP	FAM214B	326	Q7L5A3
PPFLPLPLTKPRSIS	FGD5	751	Q6ZNL6
TPISKPPPPLETSLP	KANK1	116	Q14678
GSPKPLQPLPTPVLT	MNT	161	Q99583
LAPQQPPPPTLGTLK	MNT	186	Q99583
PPPPTLGTLKLAPAE	MNT	191	Q99583
VLAPAPTPPSSGIPI	GGA3	341	Q9NZ52
PPPPLTLVLSSGPAS	KMT2B	2256	Q9UMN6
LVISPPAPSPRKTPV	MKI67	576	P46013
LPPKASLLPGPPEAS	DGKH	466	Q86XP1
PSGLLAKPPRTAQPP	HCN3	741	Q9P1Z3
GVISPALTPSPSPLP	HECTD4	826	Q9Y4D8
SSLPEAPLKPPGPLV	GOLGA3	21	Q08378
SPPLPPKRGIPSTSV	PHACTR4	291	Q8IZ21
LPSVGAKALPTAPPP	INF2	446	Q27J81
PGLTEIPPGVPLPSK	NDOR1	161	Q9UHB4
VPIKPTPAAVPALPA	FOXB1	261	Q99853
APPIAPPGTPAVVLK	MED14	1346	O60244
ALSPPKTPSLLPPLG	POM121C	601	A8CG34
SPVAPCVKTPIPGPT	NTN3	416	O00634
SPPKTPSLLPPLGLS	POM121	626	Q96HA1
GPIPFSLPEGLPKIP	NEFH	416	P12036
SKTPPGALLGAPPPL	FBRS	426	Q9HAH7
PASKLPPPLSAPVAG	CBX2	196	Q14781
DSGKLISPPVPPRPT	DOCK4	1781	Q8N1I0
IPPPVAIGKGPASTP	CC2D1A	191	Q6P1N0
STSPKPSPIPSPVLG	EHBP1	426	Q8NDI1
PSPIPSPVLGRKPNA	EHBP1	431	Q8NDI1
VPLPSNLPLPTVKPG	MBD5	401	Q9P267
LPRPIPKVPVSAPSS	CBL	591	P22681
KSPPVASPGAPVPSL	EMILIN2	891	Q9BXX0
GKDIPAPSPPLPLLS	FHOD1	566	Q9Y613
RTPTPIQPKPAGVLP	BICRA	346	Q9NZM4
TKALAAIPPPVPPSA	DUSP4	161	Q13115
KLGATPLPPESTPAP	SALL2	146	Q9Y467
IKPVLSLGPAAPPPP	PPRC1	1331	Q5VV67
TPPGVATPPIPKITI	MED1	1051	Q15648
PITPLEPGPEKTPIA	LIPE	21	Q05469
PSPGTVLALAKPPSP	OTUD5	476	Q96G74
TTGRAPKLQPPLPPE	MAP3K14	706	Q99558
PPGGPLVLSTLPSTP	NUTM2A	171	Q8IVF1
GTPLPPKALPTAGLP	GRIN3B	261	O60391
NIPLSSPLPGVPKPV	PMPCA	41	Q10713
SPPPPKVVNPLIGLL	RBM6	891	P78332
VLPKTNPTIGPAPPP	SRGAP1	1061	Q7Z6B7
SLPPLPAKPAGSPRL	SERTAD4-AS1	6	Q5TG53
IKSGPSVPPLVNPPL	SEC24A	186	O95486
TKPLPSIDSLGPPPP	FYB2	266	Q5VWT5
SAILTVLRKPNPPPP	PRR16	111	Q569H4
SPLGKPAVPPGTPTA	NCAN	921	O14594
PPPVLLTPKAVGTPG	PRRC2A	1341	P48634
TPTPRPPLPVKSPAV	INPP5D	1136	Q92835
KSVPTVSGPLAAPPP	SPATA31E1	911	Q6ZUB1
PPALVSPTPPKLSPG	DIP2C-AS1	166	Q8N8Z3
PNKTISGPLIPPASP	WIPF3	136	A6NGB9
LPPPLPSSSPIKTPL	WIPF3	186	A6NGB9
PSSSPIKTPLVSPPG	WIPF3	191	A6NGB9
PLTKGNLPVVAPPVP	WIPF3	206	A6NGB9
ANLPPPPALKPLSSL	RERE	961	Q9P2R6
PSPVPSPILGTIPSA	SELENOV	226	P59797
AGLTPPLSPPKSVPP	PRR12	1301	Q9ULL5
PLSPPKSVPPSVPAR	PRR12	1306	Q9ULL5
LKPTPPAPVRLSPAP	SRCAP	1106	Q6ZRS2
LSPAPPPGSSSLLKP	SRCAP	1116	Q6ZRS2
PPGSSSLLKPLTVPP	SRCAP	1121	Q6ZRS2
VTPSSPLLLGPPSVP	SRCAP	2521	Q6ZRS2
PTVPGSPKAPFLGIP	SHANK2	826	Q9UPX8
VISDPIPGAKPLPVP	BAIAP2	266	Q9UQB8
KGPTPPLPSAPLAPE	ARID5B	536	Q14865
IPILQSVPSAPPPKA	CIC	886	Q96RK0
LTPVPVSTPSGLVPP	CIC	966	Q96RK0
GLVPPLSPATLPGPT	CIC	976	Q96RK0
TTPPAATILPKGPPA	CIC	1126	Q96RK0
PSAPLPAPSPGLKLE	C15orf39	346	Q6ZRI6
SPPPGLSKSNPVIPI	CNOT4	301	O95628
PTIIPAPAAPGKPAS	SUGP1	361	Q8IWZ8
GPKPPPATTGSVLAP	INPP5J	121	Q15735
IITGKTGVLPPPTLP	XIRP2	2236	A4UGR9
VALPGTKPTPIPPPR	RIN2	346	Q8WYP3
ALKPTPGGSQPLPTP	PHC2	251	Q8IXK0
KFPSLPPLPPAVVTG	TEX13D	236	A0A0J9YY54
FTPSPCKIPPPTRVG	TSC1	581	Q92574
PPLPKGTPPLTPSDS	ZCCHC8	486	Q6NZY4
RTPGKAPVTPLAEPP	ZFHX2	931	Q9C0A1
PTPRPLALVFKPSPL	SECTM1	216	Q8WVN6
PPPPGKTGVQSLRPL	TEP1	866	Q99973
PPPPLTSSLPAAGSK	NUFIP1	46	Q9UHK0
QPSVPATKSGLLPPP	REPS2	501	Q8NFH8
PAPPGTLAPATTPVL	SPEM3	376	A0A1B0GUW6
RPETPPPTLPTSGKL	IGSF9B	1316	Q9UPX0
PAPPSTLSLPPKVPG	SAP130	156	Q9H0E3
PALPAKPSLLVPVGP	TNKS1BP1	51	Q9C0C2
KPPGVALPTVSPPGV	SOX10	336	P56693
PSPSKTPITLLGPRV	VWCE	906	Q96DN2
KLSGPPLQLQPTPPL	nan	251	A8MX80
VGSKPDSIPPPVPST	WIPF1	176	O43516
MTPPPPSPLLGTQVK	nan	1	Q3C1V9
FSAVVLLKGTPPPPP	ZNF598	686	Q86UK7
SKSPLPTPGAPVPVP	ZNF503	606	Q96F45
KLSGPPLQLQPTPPL	nan	251	Q8N9G6
KLSGPPLQLQPTPPL	nan	251	A8MUA0
SKSLLPGLSASPPPP	TOX2	361	Q96NM4
GLTLPPVPFTKLPIV	TRAPPC9	526	Q96Q05
PSKPPLTKAPVLPVG	WNK1	1751	Q9H4A3
PGDSKAVLPPTLPQP	PRR11	166	Q96HE9
SPSASSLGPILPPLP	SHC1	36	P29353
SRPPPGLTGQKPPLS	TNRC6A	1731	Q8NDV7
PLPPILGSPTKAVPS	ULK1	616	O75385
PLSVSIPGPIPAPIS	TPRX2	196	P0DV77
APPSLPLTIPAPVKA	YEATS2	351	Q9ULM3
PPAPPKLILLPSSSA	ZNF628	736	Q5EBL2
ALPLSVPSPLSPIGK	KMT2D	1046	O14686
TPTLPPKGLAGPPAS	KIAA1522	531	Q9P206
PKGAPTPSAVTPLSP	NACA	861	E9PAV3
PLPKGAPTTPAATLP	NACA	1051	E9PAV3
KGAPTPPAATPPSLK	NACA	1261	E9PAV3
PAVTPPSPKGTPTLP	NACA	1336	E9PAV3
PSPKGDPTSPAVIPL	NACA	1396	E9PAV3
SKGPLSTVAPAPLLP	NACA	1726	E9PAV3